rfhg_135624.1

Basic information about the TSS

---

TSS ID: rfhg_135624.1 Species: human Chr: chr11		Start: 33706549 End: 33706552 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	-
Category:	-

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AL080087:-23 GeneID: 966 HGNC/MGI_ID: HGNC:1689 UniProt_ID: Nearer transcript ids and distances:

Gene_name: CD59 molecule (CD59 blood group) Gene_symbol: CD59 Gene_synonyms: 16.3A5 EJ16 EJ30 EL32 G344 p18-20 Gene_source: HGNC:1689

TATA-Box annotation

---

Distance to TSS:	-5810
Nearest PromoterID:	NM_001166692
Entrez ID:	100131378
Nearest Unigene:	Hs.709466
Nearest Refseq:	NM_001166692
Nearest Ensembl:	ENSG00000205177
Gene Name:	CD59 molecule (CD59 blood group)
Gene Alias:	-
Gene Type:	protein-coding
CpG%:	0.000000
GC%:	0.000000
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CD59 p2@CD59 p3@CD59 p4@CD59 p5@CD59 p6@CD59 p7@CD59 p9@CD59
Sample		p1@CD59	p2@CD59	p3@CD59	p4@CD59	p5@CD59	p6@CD59	p7@CD59	p9@CD59
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	76.95	0.78	1.56	0.78	0.00	0.00	0.00	0.19
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	71.62	1.01	1.01	1.21	0.00	0.00	0.00	0.81
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	81.21	0.58	0.58	0.58	0.19	0.00	0.00	0.77
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	65.91	0.83	1.04	0.62	0.00	0.21	0.00	0.62
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	75.59	0.45	0.45	0.90	0.00	0.22	0.00	0.22
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	73.07	0.78	0.00	0.58	0.19	0.00	0.00	0.39
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	89.55	0.65	0.65	0.22	0.00	0.00	0.00	0.22
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	98.58	0.73	0.48	1.45	0.24	0.00	0.00	0.24
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	96.17	0.64	1.50	1.71	0.00	0.00	0.00	0.43
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	67.24	2.32	1.16	1.16	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	65.89	1.62	0.81	0.00	0.00	0.00	0.00	0.00
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	53.66	0.81	0.81	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	154.75	2.26	1.77	0.81	0.00	0.00	0.00	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	155.31	1.50	3.16	1.20	0.00	0.00	0.00	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	166.42	1.98	2.85	0.88	0.22	0.00	0.00	0.88
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	146.87	2.26	2.01	1.01	0.00	0.00	0.00	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	134.10	1.31	3.28	0.00	0.00	0.00	0.00	1.31
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	118.95	2.53	2.53	1.69	0.00	0.00	0.00	0.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	130.09	1.07	2.67	1.07	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	187.00	0.75	1.50	1.20	0.00	0.15	0.00	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	157.58	1.20	3.34	0.94	0.00	0.00	0.00	1.87
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	185.05	1.90	3.28	1.21	0.00	0.00	0.00	2.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	151.88	2.20	3.23	1.55	0.00	0.00	0.00	1.55
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	157.01	1.70	2.18	0.49	0.00	0.00	0.00	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	150.67	4.39	2.84	0.26	0.00	0.00	0.00	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	152.24	2.53	2.22	0.32	0.00	0.00	0.00	2.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	155.50	2.75	1.10	1.10	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	228.44	3.06	4.48	1.65	0.24	0.00	0.00	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	193.18	2.26	3.55	1.29	0.00	0.00	0.00	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	201.05	2.17	3.44	1.27	0.00	0.00	0.00	1.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	193.43	2.30	1.67	1.05	0.00	0.00	0.00	1.67
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	177.80	1.56	2.34	0.78	0.00	0.00	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	175.58	3.38	4.01	0.63	0.00	0.00	0.00	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	286.83	2.97	2.31	0.82	0.00	0.00	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	219.15	2.62	3.74	2.06	0.00	0.00	0.00	0.75
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	184.34	1.53	3.45	0.96	0.00	0.00	0.00	1.15
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	234.63	2.25	3.47	2.25	0.20	0.00	0.00	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	203.10	1.61	4.84	1.21	0.00	0.00	0.20	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	254.44	2.16	5.13	1.35	0.00	0.00	0.00	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	235.26	1.68	3.12	0.72	0.00	0.00	0.00	1.68
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	193.15	2.59	4.47	1.41	0.00	0.00	0.00	3.06
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	237.01	1.90	1.76	0.73	0.00	0.00	0.00	1.76
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	285.76	2.74	5.27	0.84	0.00	0.00	0.00	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	218.18	4.02	3.32	1.05	0.00	0.00	0.00	1.40
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	283.29	2.61	5.02	1.61	0.00	0.00	0.00	4.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	257.31	3.95	4.42	2.56	0.00	0.00	0.00	3.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	229.35	1.92	3.60	1.44	0.00	0.00	0.00	4.08
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	271.82	1.19	5.96	1.19	0.00	0.00	0.00	1.79
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	263.31	3.35	5.51	0.48	0.00	0.00	0.00	2.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	303.70	2.83	3.84	0.20	0.00	0.00	0.20	2.43
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	348.83	3.28	4.10	4.30	0.00	0.00	0.00	3.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	366.03	4.23	4.67	3.78	0.00	0.00	0.00	2.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	1077.40	363.80	0.00	0.00	0.00	0.00	0.00	41.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	319.37	1.77	3.19	2.48	0.00	0.00	0.00	2.13
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	355.91	2.32	2.65	4.97	0.33	0.00	0.00	2.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	709.74	11.75	2.52	5.87	0.00	0.00	0.00	0.84
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	594.72	7.35	4.13	0.92	0.46	0.00	0.00	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	417.45	2.27	4.54	4.54	0.32	0.00	0.00	4.21
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	352.00	3.85	3.21	1.93	0.00	0.00	0.00	2.57
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	690.27	5.97	5.66	1.57	0.00	0.00	0.00	4.09
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	418.10	2.82	4.94	3.53	0.00	0.00	0.00	2.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	390.31	3.93	3.36	3.36	0.00	0.00	0.00	2.24
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	755.54	31.85	0.80	3.18	0.80	0.00	0.00	3.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	687.69	6.12	3.74	3.40	0.00	0.00	0.00	4.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	478.93	3.57	4.87	3.57	0.00	0.00	0.00	2.60
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	441.95	3.55	3.19	5.32	0.00	0.00	0.00	1.42
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	1584.07	711.21	16.16	0.00	0.00	0.00	0.00	0.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	1666.37	213.23	7.90	15.79	0.00	0.00	0.00	7.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	398.79	2.93	2.44	5.85	0.00	0.00	0.00	0.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	486.95	3.47	3.97	4.96	0.00	0.00	0.00	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	504.30	3.75	1.88	2.35	0.00	0.00	0.00	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	587.20	5.63	1.66	2.32	0.33	0.00	0.00	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	459.68	6.50	1.86	5.88	0.00	0.31	0.00	0.62
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	408.17	3.67	2.45	3.67	0.31	0.61	0.00	2.14
Adipocyte - breast, donor1	11376-118A8	603.44	5.54	1.90	1.74	0.63	0.16	0.00	1.27
Adipocyte - breast, donor2	11327-117E4	307.70	3.21	2.25	2.73	0.16	0.32	0.16	0.96
Adipocyte - omental, donor1	11473-119C6	488.94	3.44	2.04	1.02	0.25	0.13	0.00	1.91
Adipocyte - omental, donor2	11474-119C7	475.41	0.00	2.99	5.23	0.00	0.75	0.75	0.00
Adipocyte - omental, donor3	11475-119C8	257.22	2.68	0.67	2.34	0.00	0.33	0.00	1.00
Adipocyte - perirenal, donor1	11476-119C9	517.41	7.66	0.64	9.57	0.64	0.00	0.00	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	129.74	1.10	1.10	1.10	1.10	0.00	0.00	1.10
Adipocyte - subcutaneous, donor2	11336-117F4	472.40	4.06	0.90	3.16	2.26	1.35	0.00	0.90
Adipocyte - subcutaneous, donor3	11408-118E4	121.82	0.70	1.91	0.35	0.00	0.00	0.00	1.22
Adipocyte differentiation, day04, donor1	13019-139D4	218.06	1.76	2.93	0.59	0.20	0.20	0.00	2.35
Adipocyte differentiation, day04, donor2	13022-139D7	114.53	0.26	2.06	0.26	0.00	0.00	0.00	1.03
Adipocyte differentiation, day04, donor3	13025-139E1	195.14	1.95	3.07	0.56	0.00	0.28	0.00	0.56
Adipocyte differentiation, day04, donor4	13028-139E4	92.29	2.35	1.76	0.00	0.00	0.00	0.00	1.18
Adipocyte differentiation, day08, donor1	13020-139D5	133.52	1.21	2.82	0.08	0.08	0.00	0.08	0.88
Adipocyte differentiation, day08, donor2	13023-139D8	177.84	2.58	2.26	0.97	0.65	0.00	0.00	2.26
Adipocyte differentiation, day08, donor3	13026-139E2	187.15	2.13	1.60	2.13	0.00	0.00	0.00	0.53
Adipocyte differentiation, day08, donor4	13029-139E5	85.13	3.34	0.56	0.56	0.00	0.00	0.56	1.11
Adipocyte differentiation, day12, donor1	13021-139D6	115.62	0.00	3.33	2.08	0.00	0.42	0.00	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	203.70	1.00	3.01	0.00	0.00	0.50	0.00	1.00
Adipocyte differentiation, day12, donor3	13027-139E3	156.42	1.64	1.96	0.33	0.33	0.33	0.00	1.96
Adipocyte differentiation, day12, donor4	13030-139E6	56.02	1.83	1.52	0.30	0.00	0.00	0.00	0.61
Alveolar Epithelial Cells, donor1	11510-119G7	341.22	1.10	3.31	0.44	0.44	0.44	0.22	1.99
Alveolar Epithelial Cells, donor2	11590-120G6	51.64	0.00	1.79	0.00	0.00	0.00	0.00	0.36
Alveolar Epithelial Cells, donor3	11671-122G6	82.66	1.20	0.00	0.00	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	692.28	7.56	1.98	1.80	2.70	3.78	1.26	1.80
Amniotic Epithelial Cells, donor2	11613-122A2	532.17	18.41	0.00	0.00	1.67	5.02	1.67	0.00
Amniotic Epithelial Cells, donor3	11694-123A2	500.67	5.34	2.26	1.44	1.64	1.03	0.41	1.03
Anulus Pulposus Cell, donor1	11248-116E6	700.06	3.43	2.52	2.29	0.11	0.11	0.00	2.63
Anulus Pulposus Cell, donor2	11463-119B5	450.87	2.69	2.45	5.88	0.24	0.24	0.24	1.96
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	363.93	8.54	2.70	7.64	0.00	0.45	0.00	1.80
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	388.99	8.25	3.91	3.04	0.00	0.43	0.00	1.30
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	479.42	2.14	8.56	8.56	0.00	0.00	0.00	2.14
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	413.11	11.06	2.09	8.37	0.90	0.60	0.30	0.60
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	528.62	7.59	0.00	10.12	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	396.04	4.62	1.32	5.94	0.00	0.66	0.66	0.66
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	358.35	10.72	1.62	4.22	1.95	0.65	0.00	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	405.83	9.22	1.46	3.88	0.97	0.49	0.00	2.91
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	438.28	8.91	2.97	3.56	0.00	0.00	0.00	1.19
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	428.61	6.03	2.26	7.53	0.38	0.38	0.00	0.75
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	396.94	10.89	2.18	5.08	0.00	0.00	0.00	2.18
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	412.49	5.02	1.25	6.27	0.00	0.00	0.00	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	609.52	4.78	3.29	2.14	0.00	0.49	0.00	0.99
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	301.62	5.46	2.73	1.36	0.00	0.00	0.00	1.36
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	659.56	8.60	3.02	3.17	0.15	0.60	0.00	1.81
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	376.66	12.32	2.14	2.14	1.07	1.07	0.00	3.21
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	452.69	7.56	2.46	6.05	0.19	0.19	0.00	1.13
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	411.35	9.09	3.74	6.15	0.00	0.00	0.00	0.80
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	297.51	2.93	0.98	5.85	0.00	0.00	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	482.82	8.46	3.15	3.48	0.17	0.50	0.00	1.66
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	390.23	7.20	3.60	3.60	2.40	2.40	0.00	2.40
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	240.73	7.08	0.00	3.54	3.54	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	457.47	7.55	2.57	3.95	0.34	0.00	0.00	1.54
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	339.79	0.00	8.39	4.19	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	416.49	10.68	4.37	4.85	0.00	0.00	0.00	3.88
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	524.40	6.83	1.90	3.04	0.38	1.14	0.38	1.14
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	397.33	12.11	0.00	6.06	0.00	0.00	0.00	2.42
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	409.85	7.98	3.42	3.99	0.57	0.57	0.00	0.57
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	433.32	9.19	4.06	2.57	0.43	0.21	0.00	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	379.91	10.58	3.10	2.32	0.26	0.00	0.00	1.55
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	377.24	5.63	1.41	2.82	0.00	0.47	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	428.30	7.72	1.93	3.54	0.64	0.32	0.00	0.96
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	453.76	9.99	0.00	2.85	0.71	0.00	0.00	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	391.92	8.77	5.26	3.51	0.58	0.58	0.00	2.34
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	430.83	7.53	0.60	5.42	0.30	0.60	0.00	1.20
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	475.20	13.07	3.56	4.75	1.19	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	488.73	7.12	2.03	7.63	0.51	0.51	0.00	0.00
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	547.58	6.37	2.80	6.37	0.76	0.76	0.00	3.57
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	423.16	6.35	2.54	3.81	0.00	1.27	0.00	1.27
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	394.85	14.24	3.45	2.59	1.29	0.43	0.00	1.73
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	481.16	9.31	2.12	2.33	0.42	0.42	0.00	1.91
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	399.01	12.47	3.19	6.38	0.29	0.58	0.00	2.03
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	356.17	11.34	1.89	4.72	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	445.34	9.83	3.22	2.88	0.17	0.34	0.17	2.20
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	354.40	16.21	2.32	4.63	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	264.07	4.23	2.11	2.11	0.00	0.00	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	475.14	7.08	2.79	3.00	0.64	0.64	0.43	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	418.76	5.41	1.80	3.61	0.00	0.00	0.00	1.80
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	408.23	8.02	6.56	6.56	0.00	0.73	0.00	1.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	526.20	6.67	1.84	5.29	0.23	0.69	0.00	0.46
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	357.04	15.30	2.55	2.55	0.00	0.00	0.00	10.20
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	692.53	13.98	3.56	3.05	0.25	0.51	0.25	2.03
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	465.31	10.53	3.51	4.13	0.41	0.21	0.00	2.48
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	374.24	11.02	1.84	2.45	0.00	0.00	0.00	0.61
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	434.04	8.13	3.35	5.74	0.00	0.48	0.00	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	451.68	9.98	3.77	3.99	0.22	0.89	0.00	1.77
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	532.50	4.58	4.58	4.58	0.00	1.53	0.00	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	406.00	7.20	4.43	3.88	0.00	0.00	0.00	1.11
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	443.27	7.68	2.91	2.65	0.00	0.00	0.00	2.38
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	412.15	11.27	3.27	4.00	0.00	0.00	0.00	2.54
Astrocyte - cerebellum, donor1	11500-119F6	119.50	0.86	2.09	0.00	0.12	0.12	0.00	0.61
Astrocyte - cerebellum, donor2	11580-120F5	87.12	0.51	1.54	0.17	0.00	0.17	0.00	0.34
Astrocyte - cerebellum, donor3	11661-122F5	37.13	0.21	0.84	0.00	0.00	0.00	0.00	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	497.78	3.49	3.14	1.05	0.00	0.00	0.00	1.74
Astrocyte - cerebral cortex, donor2	11316-117D2	336.65	2.91	4.04	2.91	0.00	0.00	0.00	2.26
Astrocyte - cerebral cortex, donor3	11392-118C6	375.88	2.68	4.92	1.49	0.15	0.00	0.00	2.83
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	72.48	0.46	3.33	0.34	0.11	0.00	0.00	1.83
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	75.42	0.50	2.88	0.00	0.00	0.13	0.00	1.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	68.96	0.57	2.73	0.34	0.00	0.00	0.00	1.48
Basophils, donor1	12241-129G9	9.68	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Basophils, donor2	12242-129H1	18.76	0.00	0.72	0.00	0.00	0.00	0.00	0.36
Basophils, donor3	12243-129H2	39.40	0.44	0.15	0.15	0.44	0.00	0.00	0.44
Bronchial Epithelial Cell, donor1	11511-119G8	159.33	0.65	1.08	0.22	0.22	0.22	0.00	1.08
Bronchial Epithelial Cell, donor2	11591-120G7	38.86	0.46	0.00	0.00	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	150.64	0.00	0.00	7.17	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor4	11453-119A4	173.86	1.26	1.88	1.26	0.00	0.00	0.00	0.00
Bronchial Epithelial Cell, donor5	11457-119A8	161.16	0.42	2.08	0.62	0.00	0.00	0.00	0.83
Bronchial Epithelial Cell, donor6	11461-119B3	156.14	2.07	1.38	1.38	0.23	0.00	0.00	0.92
Bronchial Epithelial Cell, donor7	11769-123I5	233.57	5.76	0.54	1.98	0.00	0.00	0.00	0.54
Burkitt's lymphoma cell line:DAUDI	10422-106C8	7.52	0.10	0.82	0.00	0.00	0.00	0.00	0.10
Burkitt's lymphoma cell line:RAJI	10476-106I8	23.76	0.23	0.23	0.47	0.00	0.00	0.00	0.70
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	141.66	0.64	4.48	0.00	0.00	0.00	0.00	3.20
CD133+ stem cells - cord blood derived, pool1	12223-129E9	72.39	0.00	10.34	0.00	0.00	0.00	0.00	10.34
CD14+ Monocytes, donor1	11224-116B9	16.34	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+ Monocytes, donor2	11305-117B9	4.83	0.19	0.37	0.00	0.00	0.37	0.00	0.00
CD14+ Monocytes, donor3	11381-118B4	7.46	0.22	0.66	0.00	0.00	0.44	0.00	0.00
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	974.24	15.00	6.79	2.26	0.57	0.28	0.00	3.40
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	801.36	10.61	4.93	2.65	1.52	0.00	0.00	3.41
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	855.38	4.27	7.89	1.64	0.33	0.00	0.33	3.29
CD14+ monocytes - mock treated, donor1	11863-125A9	6.65	0.14	0.29	0.14	0.00	0.14	0.00	0.14
CD14+ monocytes - mock treated, donor2	11873-125C1	11.47	0.30	0.30	0.00	0.91	0.60	0.00	0.60
CD14+ monocytes - mock treated, donor3	11883-125D2	14.45	0.24	0.95	0.00	0.24	0.24	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	4.69	0.17	0.33	0.17	0.17	0.00	0.00	0.17
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	16.56	0.28	0.28	0.28	0.55	0.83	0.00	0.00
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	20.33	0.00	0.00	0.00	0.50	0.74	0.00	0.25
CD14+ monocytes - treated with BCG, donor1	11860-125A6	12.92	0.59	0.59	0.00	0.78	0.59	0.00	0.20
CD14+ monocytes - treated with BCG, donor2	11870-125B7	30.98	0.53	0.36	0.00	4.63	3.56	0.00	0.71
CD14+ monocytes - treated with BCG, donor3	11880-125C8	102.72	0.65	1.96	1.09	6.96	6.53	0.44	1.09
CD14+ monocytes - treated with Candida, donor1	11868-125B5	7.73	0.00	0.00	0.00	0.00	0.47	0.00	0.23
CD14+ monocytes - treated with Candida, donor2	11878-125C6	28.51	0.00	0.00	0.00	1.06	1.58	0.00	0.00
CD14+ monocytes - treated with Candida, donor3	11888-125D7	34.39	0.00	0.00	0.00	1.11	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	4.31	0.00	0.00	0.15	0.15	0.00	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	15.17	0.20	0.20	0.00	0.60	0.20	0.00	0.00
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	27.27	0.00	0.00	0.00	0.62	1.25	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	8.47	0.23	0.23	0.00	0.23	0.00	0.00	0.23
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	15.61	0.00	0.00	0.00	0.90	0.68	0.00	0.00
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	16.15	0.44	0.44	0.00	0.44	0.00	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	7.26	1.08	0.00	0.00	0.27	0.27	0.00	0.00
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	41.35	0.70	0.70	0.00	4.19	4.88	0.00	0.17
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	76.59	0.00	2.52	0.00	3.37	5.05	0.00	0.84
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	14.51	0.55	0.37	0.18	0.18	0.18	0.00	0.00
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	34.17	0.35	0.70	0.00	1.06	0.00	0.00	0.35
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	33.34	0.88	0.44	0.00	0.88	0.88	0.00	0.88
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	17.96	0.35	0.17	0.52	0.87	1.39	0.00	0.52
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	64.67	1.49	0.37	0.00	4.09	4.83	0.37	0.37
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	118.34	0.43	1.94	0.43	6.47	9.48	0.65	0.65
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	23.75	0.00	0.82	0.00	0.00	0.41	0.00	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	30.60	0.00	1.16	0.23	0.23	0.70	0.23	0.00
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	43.15	0.00	0.70	0.23	1.39	1.39	0.00	0.00
CD14+CD16+ Monocytes, donor1	11789-124B7	2.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor2	11801-124D1	1.85	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16+ Monocytes, donor3	11912-125G4	2.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor1	11788-124B6	9.81	0.00	0.16	0.00	0.00	0.00	0.00	0.16
CD14+CD16- Monocytes, donor2	11799-124C8	5.06	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14+CD16- Monocytes, donor3	11910-125G2	4.24	0.00	0.45	0.00	0.00	0.00	0.00	0.22
CD14-CD16+ Monocytes, donor1	11790-124B8	0.51	0.00	0.00	0.00	0.00	0.00	0.00	0.26
CD14-CD16+ Monocytes, donor2	11800-124C9	0.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD14-CD16+ Monocytes, donor3	11911-125G3	0.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	18.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	44.75	0.68	1.36	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	21.75	0.00	0.00	0.00	0.00	0.00	0.00	1.04
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	41.04	1.07	1.07	0.00	0.00	0.00	0.00	1.07
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	23.05	0.00	1.61	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	41.41	0.00	0.70	0.00	0.00	0.00	0.00	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	41.57	0.00	0.78	0.00	0.00	0.00	0.00	1.57
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	47.46	0.00	2.64	1.32	0.00	0.00	0.00	1.32
CD19+ B Cells, donor1	11544-120B5	18.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor2	11624-122B4	26.12	0.00	1.45	0.00	0.00	0.00	0.00	0.00
CD19+ B Cells, donor3	11705-123B4	21.71	0.50	0.50	0.00	0.00	0.00	0.00	0.50
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	459.82	3.64	3.23	0.81	0.00	0.00	0.00	4.44
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	434.65	2.40	3.20	1.60	0.00	0.00	0.00	4.79
CD34+ Progenitors, donor1	11545-120B6	55.22	0.00	1.00	0.00	0.00	0.00	0.00	0.00
CD34+ Progenitors, donor2	11625-122B5	42.14	1.12	1.12	0.00	0.00	0.00	0.00	0.00
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	100.33	0.38	3.01	0.38	0.00	0.00	0.00	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	111.39	0.68	3.83	0.23	0.00	0.00	0.00	2.48
CD4+ T Cells, donor1	11225-116C1	33.92	0.36	0.00	0.36	0.00	0.00	0.00	0.71
CD4+ T Cells, donor2	11306-117C1	27.56	0.00	1.22	0.00	0.00	0.00	0.00	0.61
CD4+ T Cells, donor3	11382-118B5	28.97	0.61	0.61	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	115.37	0.51	2.81	0.51	0.00	0.00	0.00	1.53
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	113.20	3.14	3.14	0.22	0.00	0.00	0.00	2.47
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	111.25	2.01	3.45	0.29	0.00	0.00	0.00	0.57
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	54.52	0.47	2.37	0.00	0.00	0.00	0.00	0.47
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	67.42	0.70	2.81	0.00	0.00	0.00	0.00	0.70
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	69.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	125.87	1.01	3.03	0.29	0.00	0.00	0.00	1.59
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	168.11	3.73	5.08	0.68	0.00	0.00	0.00	2.20
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	189.74	5.00	8.06	0.97	0.00	0.00	0.00	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	83.83	0.90	2.69	0.00	0.00	0.00	0.00	0.45
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	139.06	0.35	4.54	1.05	0.00	0.00	0.00	2.10
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	94.16	1.76	2.64	0.44	0.00	0.00	0.00	0.44
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	56.92	0.42	0.84	0.00	0.00	0.42	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	56.51	1.66	1.66	0.00	0.00	0.00	0.00	0.83
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	47.45	1.00	0.67	0.33	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	32.09	0.27	1.90	0.00	0.00	0.00	0.00	0.27
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	42.88	0.54	1.61	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	37.66	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	110.33	0.56	1.85	0.00	0.00	0.00	0.00	1.11
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	126.07	1.52	3.47	0.00	0.00	0.00	0.00	0.87
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	116.42	2.31	2.31	0.42	0.00	0.00	0.00	1.26
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	48.03	0.00	2.02	0.00	0.00	0.00	0.00	1.52
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	64.12	0.00	2.17	0.00	0.00	0.00	0.00	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	49.68	0.00	0.87	0.00	0.00	0.00	0.00	0.87
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	61.86	0.00	2.47	0.00	0.00	0.00	0.00	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	40.62	0.00	1.85	0.00	0.00	0.00	0.00	0.92
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	39.08	1.40	2.79	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	56.77	0.28	0.83	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	59.14	0.25	1.96	0.00	0.00	0.00	0.00	0.74
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	49.28	0.00	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	47.27	0.36	0.72	0.36	0.00	0.00	0.00	1.43
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	63.71	0.00	2.77	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor1	11226-116C2	31.43	0.33	0.33	0.00	0.00	0.00	0.00	0.65
CD8+ T Cells, donor2	11307-117C2	21.02	1.13	0.00	0.00	0.00	0.00	0.00	0.00
CD8+ T Cells, donor3	11383-118B6	23.99	0.50	0.50	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	51.38	0.23	0.23	1.15	0.00	0.23	0.00	0.46
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	38.58	0.00	0.24	0.00	0.00	0.24	0.00	0.96
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	44.32	0.82	1.09	0.00	0.00	0.55	0.00	0.82
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	86.76	0.00	0.00	0.60	0.00	0.60	0.00	0.60
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	56.88	0.48	0.72	0.48	0.00	0.96	0.00	0.24
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	57.76	0.00	0.91	0.23	0.00	0.00	0.00	0.23
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	69.97	0.43	1.09	0.65	0.00	0.22	0.00	0.22
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	58.96	0.00	1.05	1.32	0.00	1.32	0.00	0.00
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	64.96	0.70	0.47	0.00	0.00	0.00	0.00	0.23
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	58.56	0.91	0.60	0.00	0.00	0.91	0.00	0.30
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	51.42	0.00	0.29	0.58	0.00	0.29	0.29	0.58
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	74.60	0.00	0.27	0.27	0.00	0.00	0.00	0.80
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	40.71	0.88	0.00	0.00	0.00	0.44	0.44	0.00
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	50.10	1.37	0.00	0.00	0.00	0.91	0.46	0.46
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	41.77	0.75	1.49	0.00	0.00	0.00	0.00	1.49
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	57.26	0.36	0.72	0.72	0.00	0.36	0.00	0.36
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	51.79	0.58	0.86	0.29	0.29	0.29	0.00	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	50.67	0.00	1.65	0.24	0.24	0.71	0.00	0.71
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	80.81	0.32	0.95	0.63	0.63	0.63	0.00	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	74.74	0.00	0.62	0.31	0.31	0.31	0.31	0.62
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	57.71	0.32	0.64	0.32	0.00	0.64	0.00	0.96
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	53.55	0.76	0.00	0.76	0.00	0.38	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	58.33	0.00	0.39	0.79	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	37.06	0.00	0.00	0.76	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	45.77	0.00	0.80	0.00	0.00	0.00	0.00	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	58.05	0.00	0.70	0.00	1.40	0.00	0.70	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	48.08	0.00	1.00	0.00	1.00	1.00	0.00	1.00
Cardiac Myocyte, donor1	11525-119I4	334.48	0.00	1.83	5.48	0.00	0.00	0.00	3.66
Cardiac Myocyte, donor2	11605-120I3	260.88	2.47	1.48	2.47	0.49	1.48	0.00	0.49
Cardiac Myocyte, donor3	11686-122I3	251.51	1.79	1.47	0.53	0.21	0.21	0.00	1.05
Chondrocyte - de diff, donor1	11261-116G1	512.03	5.55	2.08	0.00	0.69	0.69	0.00	1.04
Chondrocyte - de diff, donor2	11338-117F6	438.89	2.13	2.13	1.07	0.00	0.00	0.00	0.00
Chondrocyte - de diff, donor3	11410-118E6	396.18	5.23	2.16	2.84	0.23	0.80	0.00	1.37
Chondrocyte - re diff, donor2	11339-117F7	537.15	3.58	3.58	0.90	1.79	0.00	0.00	1.79
Chondrocyte - re diff, donor3	11411-118E7	311.80	2.83	2.02	2.43	0.40	0.40	0.00	1.21
Ciliary Epithelial Cells, donor1	11242-116D9	216.09	1.49	1.72	0.80	0.00	0.00	0.00	1.61
Ciliary Epithelial Cells, donor2	11323-117D9	209.28	1.07	2.14	1.50	0.00	0.00	0.00	1.50
Ciliary Epithelial Cells, donor3	11399-118D4	170.45	1.24	2.21	0.44	0.00	0.00	0.00	1.50
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	260.15	3.03	3.39	1.01	0.00	0.00	0.09	1.74
Corneal Epithelial Cells, donor1	11526-119I5	103.42	0.00	0.22	0.22	0.00	0.00	0.00	0.44
Corneal Epithelial Cells, donor2	11606-120I4	55.74	0.00	0.00	1.14	0.00	0.00	0.00	0.00
Corneal Epithelial Cells, donor3	11687-122I4	95.86	0.51	0.77	0.26	0.00	0.00	0.00	0.77
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	200.26	1.49	0.83	0.66	2.48	3.14	0.00	0.50
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	258.00	5.36	1.58	1.58	3.47	2.52	0.00	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	341.62	0.00	3.45	3.45	6.90	0.00	0.00	3.45
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	129.80	2.16	0.97	0.97	2.16	1.94	0.00	0.86
Dendritic Cells - plasmacytoid, donor1	11228-116C4	9.22	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	22.20	0.65	0.00	0.65	0.00	0.00	0.00	0.00
Dendritic Cells - plasmacytoid, donor3	11385-118B8	9.68	0.00	0.97	0.00	0.00	0.00	0.00	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	574.02	8.00	2.33	0.50	1.00	0.83	0.00	1.33
Endothelial Cells - Aortic, donor1	11263-116G3	567.41	1.76	1.76	1.76	1.17	0.00	0.00	1.17
Endothelial Cells - Aortic, donor2	11340-117F8	516.11	8.77	0.85	0.28	0.85	0.85	0.00	1.13
Endothelial Cells - Aortic, donor3	11412-118E8	468.68	4.72	2.36	4.33	0.39	0.79	0.00	1.18
Endothelial Cells - Artery, donor1	11264-116G4	656.79	4.94	2.04	2.33	0.58	0.58	0.00	0.58
Endothelial Cells - Artery, donor2	11341-117F9	584.67	7.76	2.12	4.00	0.71	1.18	0.00	1.88
Endothelial Cells - Artery, donor3	11413-118E9	641.81	6.66	3.16	2.10	0.88	0.88	0.00	3.16
Endothelial Cells - Lymphatic, donor1	11236-116D3	1535.61	20.17	6.87	3.55	1.99	0.22	0.00	2.44
Endothelial Cells - Lymphatic, donor2	11317-117D3	1310.78	14.91	6.39	2.43	0.91	0.30	0.61	3.65
Endothelial Cells - Lymphatic, donor3	11393-118C7	903.50	2.54	2.26	1.69	1.13	0.28	0.00	1.69
Endothelial Cells - Microvascular, donor1	11265-116G5	447.78	6.54	3.86	0.89	0.59	0.30	0.00	1.19
Endothelial Cells - Microvascular, donor2	11342-117G1	835.67	4.69	2.08	0.52	2.08	0.00	0.00	1.04
Endothelial Cells - Microvascular, donor3	11414-118F1	266.56	2.13	1.42	0.71	0.71	0.28	0.00	1.13
Endothelial Cells - Thoracic, donor1	11266-116G6	763.83	9.20	1.60	2.80	0.80	1.60	0.00	0.80
Endothelial Cells - Thoracic, donor2	11343-117G2	596.45	5.77	2.62	4.72	0.00	0.00	0.00	3.14
Endothelial Cells - Umbilical vein, donor1	11243-116E1	796.92	11.06	4.10	2.61	1.49	0.75	0.25	3.11
Endothelial Cells - Umbilical vein, donor2	11324-117E1	417.36	3.69	4.13	4.13	0.65	0.22	0.00	1.74
Endothelial Cells - Umbilical vein, donor3	11400-118D5	394.47	1.59	4.76	1.47	0.61	0.37	0.00	3.79
Endothelial Cells - Vein, donor1	11267-116G7	450.45	0.00	2.28	1.14	1.14	0.00	0.00	2.28
Endothelial Cells - Vein, donor2	11344-117G3	616.08	2.10	0.70	0.70	0.00	0.00	0.00	0.70
Endothelial Cells - Vein, donor3	11416-118F3	535.39	5.50	3.45	2.04	1.41	1.73	0.00	1.57
Eosinophils, donor1	12244-129H3	60.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Eosinophils, donor2	12245-129H4	100.67	0.00	1.65	0.00	0.00	0.00	0.00	1.65
Eosinophils, donor3	12246-129H5	89.17	10.70	3.57	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	122.65	1.47	0.73	0.00	0.00	0.00	0.00	0.98
Esophageal Epithelial Cells, donor2	11587-120G3	56.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	244.03	0.00	16.27	0.00	0.00	0.00	0.00	0.00
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	471.68	4.52	0.82	1.23	0.82	0.41	0.00	3.28
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	671.71	3.50	2.85	15.88	0.22	0.66	0.11	2.30
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	100.00	0.43	4.23	1.52	0.22	0.22	0.00	1.73
Fibroblast - Aortic Adventitial, donor1	11245-116E3	850.90	4.97	3.15	3.76	0.73	1.21	0.00	2.18
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	648.38	2.59	1.36	1.23	0.00	0.27	0.00	1.50
Fibroblast - Aortic Adventitial, donor2	11326-117E3	401.41	3.16	2.85	1.48	0.11	0.00	0.00	0.95
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	1286.36	2.11	1.58	3.43	1.05	0.79	0.00	1.58
Fibroblast - Aortic Adventitial, donor3	11401-118D6	647.79	1.33	3.32	1.33	0.66	0.66	0.00	2.33
Fibroblast - Cardiac, donor1	11268-116G8	420.06	0.91	1.81	3.63	0.91	0.00	0.00	1.81
Fibroblast - Cardiac, donor2	11345-117G4	472.96	1.52	0.76	1.52	0.76	0.76	0.00	0.76
Fibroblast - Cardiac, donor3	11417-118F4	417.79	1.42	2.52	1.26	0.95	1.26	0.00	1.10
Fibroblast - Cardiac, donor4	11452-119A3	397.68	1.82	1.82	0.00	0.00	0.30	0.00	0.91
Fibroblast - Cardiac, donor5	11456-119A7	528.56	4.57	3.68	2.03	0.89	0.76	0.25	1.52
Fibroblast - Cardiac, donor6	11460-119B2	740.23	5.00	2.88	4.55	1.21	1.97	0.45	1.67
Fibroblast - Choroid Plexus, donor1	11492-119E7	190.53	1.07	1.74	0.00	0.13	0.00	0.00	0.94
Fibroblast - Choroid Plexus, donor2	11572-120E6	209.67	0.43	1.29	1.73	0.00	0.00	0.00	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	446.76	4.39	0.00	7.32	2.93	0.00	0.00	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	71.50	0.00	1.85	0.00	0.00	0.00	0.00	0.69
Fibroblast - Conjunctival, donor3	11692-122I9	197.76	0.68	2.20	0.68	0.00	0.17	0.00	1.53
Fibroblast - Dermal, donor1	11269-116G9	461.35	1.64	3.76	1.17	2.58	0.70	0.00	2.82
Fibroblast - Dermal, donor2	11346-117G5	576.39	3.30	3.30	1.42	1.89	0.47	0.00	0.94
Fibroblast - Dermal, donor3	11418-118F5	649.52	11.85	2.66	3.26	1.69	1.21	0.12	2.18
Fibroblast - Dermal, donor4	11450-119A1	332.35	2.26	2.94	2.37	1.58	0.79	0.00	1.81
Fibroblast - Dermal, donor5	11454-119A5	355.54	1.40	3.49	2.62	1.92	1.74	0.00	2.09
Fibroblast - Dermal, donor6	11458-119A9	442.93	4.06	2.60	3.41	1.79	2.60	0.16	1.95
Fibroblast - Gingival, donor1	11237-116D4	615.74	8.12	2.08	1.04	1.67	0.83	0.00	2.08
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	533.96	1.05	2.88	1.31	0.52	0.00	0.00	1.31
Fibroblast - Gingival, donor2	11318-117D4	401.94	3.82	4.22	4.09	0.40	0.26	0.00	2.24
Fibroblast - Gingival, donor3	11394-118C8	322.26	3.19	2.13	0.68	0.58	0.48	0.10	1.74
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	357.38	2.08	4.16	0.00	0.00	1.04	0.00	2.08
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	198.93	1.94	1.41	1.23	0.00	0.18	0.00	1.06
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	460.05	2.49	2.03	1.09	0.16	0.47	0.00	2.34
Fibroblast - Gingival, donor6 (control)	11922-125H5	423.94	3.92	3.92	1.89	0.95	0.54	0.00	2.16
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	227.96	0.00	2.47	0.35	1.76	0.35	0.00	1.76
Fibroblast - Gingival, donor7 (control)	11924-125H7	378.48	3.95	2.78	1.32	1.61	0.58	0.00	2.78
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	421.33	4.50	3.41	1.36	0.55	0.55	0.00	3.00
Fibroblast - Gingival, donor8 (control)	11926-125H9	348.60	2.85	3.29	2.19	1.32	0.77	0.11	2.41
Fibroblast - Gingival, donor9 (control)	11927-125I1	282.62	1.61	3.23	1.03	0.00	0.15	0.00	1.61
Fibroblast - Lung, donor1	11270-116H1	212.06	1.36	1.36	2.72	0.00	0.00	0.00	2.72
Fibroblast - Lung, donor2	11347-117G6	477.49	1.49	1.49	1.49	0.00	0.00	0.00	4.48
Fibroblast - Lung, donor3	11419-118F6	372.90	6.54	1.48	2.32	0.21	0.84	0.00	1.27
Fibroblast - Lymphatic, donor1	11506-119G3	124.12	0.00	0.00	0.83	0.00	0.83	0.00	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	116.09	1.40	4.20	1.40	0.00	0.00	0.00	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	50.38	0.00	0.56	0.00	0.28	0.00	0.00	0.28
Fibroblast - Mammary, donor1	11540-120B1	345.48	0.41	1.62	0.00	0.41	0.41	0.00	1.62
Fibroblast - Mammary, donor2	11620-122A9	107.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	160.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	453.70	3.69	2.91	1.94	0.39	0.00	0.00	2.33
Fibroblast - Periodontal Ligament, donor2	11319-117D5	308.98	2.43	3.79	1.21	1.06	0.30	0.00	2.58
Fibroblast - Periodontal Ligament, donor3	11395-118C9	565.16	3.98	1.84	0.31	1.84	0.61	0.31	3.37
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	320.95	1.91	3.43	0.00	0.00	0.38	0.00	2.29
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	562.39	5.13	2.70	7.83	1.62	0.54	0.00	1.62
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	244.36	2.32	2.55	1.39	0.12	0.58	0.00	1.51
Fibroblast - Pulmonary Artery, donor1	11250-116E8	928.69	10.72	2.87	4.64	1.77	2.87	0.00	3.54
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	175.96	0.20	0.41	0.81	1.02	1.22	0.20	0.20
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	156.36	2.67	2.00	0.00	0.00	0.67	0.00	2.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	304.82	1.98	1.58	1.19	0.00	0.00	0.00	0.40
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	464.37	2.78	0.60	0.20	0.79	4.56	0.20	0.99
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	532.32	2.49	1.07	0.71	0.18	0.53	0.00	1.07
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	531.74	2.37	1.38	0.39	0.00	0.20	0.00	1.18
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	775.00	2.11	0.60	2.71	0.60	1.50	0.00	2.41
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	534.79	3.45	1.73	0.97	0.54	0.32	0.00	1.84
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	258.39	1.27	0.51	0.76	0.25	0.25	0.00	0.51
Fibroblast - skin normal, donor1	11553-120C5	600.03	1.97	1.80	0.66	0.66	0.98	0.00	3.12
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	791.60	5.01	1.80	1.20	1.00	4.41	0.40	2.01
Fibroblast - skin normal, donor2	11561-120D4	549.33	1.91	1.81	1.61	0.60	1.71	0.10	1.51
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	285.92	1.21	1.51	0.60	0.60	1.21	0.00	2.12
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	345.30	3.56	0.91	0.50	0.25	0.25	0.00	0.75
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	399.68	2.91	2.22	1.71	0.00	0.34	0.00	2.05
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	666.06	1.97	0.00	1.97	0.33	2.30	0.00	1.64
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	654.26	2.34	2.13	1.38	0.96	1.60	0.00	1.07
Fibroblast - skin walker warburg, donor1	11554-120C6	598.82	2.87	1.52	1.01	1.69	0.84	0.17	1.69
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	776.41	4.08	2.51	5.02	0.78	0.78	0.31	4.70
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	2437.58	66.48	22.16	22.16	22.16	0.00	0.00	22.16
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	95.87	0.87	0.87	0.87	0.00	0.00	0.87	1.74
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	820.67	3.47	2.95	2.77	0.52	1.04	0.00	1.73
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	604.28	6.77	4.42	0.78	1.30	0.00	0.26	3.64
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	490.84	7.67	1.53	0.51	0.51	0.26	0.00	2.04
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	41.34	0.77	1.53	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	37.01	0.00	0.64	0.00	0.00	0.00	0.00	0.00
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	55.91	1.43	2.28	0.00	0.00	0.00	0.00	1.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	43.85	4.41	2.21	0.28	0.00	0.00	0.00	1.65
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	55.25	0.91	4.11	1.14	0.00	0.00	0.00	0.23
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	42.00	1.59	2.18	0.40	0.00	0.00	0.00	0.59
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	49.17	2.64	2.38	0.00	0.00	0.00	0.00	0.26
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	76.64	1.63	3.59	0.65	0.00	0.00	0.33	0.98
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	44.22	2.21	0.44	0.44	0.00	0.00	0.00	0.88
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	40.14	0.42	0.57	0.14	0.00	0.00	0.00	0.28
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	39.77	0.86	1.85	0.37	0.00	0.00	0.00	0.74
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	40.56	1.88	0.27	0.54	0.00	0.00	0.00	0.27
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	75.20	0.12	1.49	0.25	0.25	0.25	0.00	0.12
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	56.89	0.42	0.97	0.14	0.00	0.00	0.00	0.97
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	49.61	0.81	2.03	0.41	0.00	0.20	0.00	0.81
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	88.76	1.37	2.74	0.46	0.00	0.00	0.00	0.91
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	88.57	0.25	1.49	0.25	0.12	0.25	0.00	1.25
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	57.05	0.22	1.53	0.22	0.00	0.00	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	94.85	0.59	2.36	0.00	0.30	0.00	0.00	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	71.53	0.32	1.27	0.48	0.00	0.00	0.00	0.64
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	77.53	1.34	1.12	0.67	0.22	0.00	0.00	1.79
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	65.33	0.60	2.22	0.40	0.00	0.00	0.00	2.42
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	87.20	0.34	2.71	0.85	0.17	0.00	0.00	0.68
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	125.03	0.53	3.01	0.09	0.35	0.27	0.00	1.42
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	92.19	0.73	1.46	0.21	0.00	0.00	0.00	1.25
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	98.20	1.02	1.37	0.34	0.00	0.00	0.00	1.88
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	74.03	0.33	2.55	0.22	0.00	0.00	0.00	0.66
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	126.71	1.16	3.08	0.17	0.08	0.17	0.08	1.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	137.41	0.82	1.63	0.00	0.00	0.20	0.20	0.82
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	107.49	1.24	2.06	0.62	0.00	0.00	0.00	1.03
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	82.32	1.27	3.00	0.12	0.00	0.00	0.00	1.04
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	101.89	0.50	2.50	0.33	0.33	0.00	0.00	0.83
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	76.49	0.44	2.42	0.22	0.00	0.00	0.00	0.22
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	104.54	0.25	2.58	0.61	0.00	0.00	0.00	1.35
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	99.20	0.81	2.27	0.49	0.32	0.16	0.00	1.62
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	105.52	1.60	1.60	0.32	0.00	0.32	0.00	0.64
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	83.95	0.38	2.56	0.28	0.09	0.00	0.00	0.76
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	88.10	0.63	1.74	0.79	0.16	0.16	0.00	0.63
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	130.76	0.91	1.82	0.61	0.61	0.00	0.00	1.22
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	105.58	1.15	1.99	0.00	0.21	0.31	0.00	1.46
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	112.63	1.10	1.76	0.44	0.00	0.00	0.00	0.44
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	129.05	0.56	2.24	1.40	0.56	0.00	0.00	1.96
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	136.29	0.46	1.94	0.46	0.09	0.09	0.00	0.93
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	169.00	0.53	2.41	0.53	0.53	0.80	0.00	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	132.81	0.15	2.45	0.46	0.61	0.31	0.00	1.38
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	129.93	0.52	1.30	0.39	0.39	0.13	0.00	1.04
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	152.61	1.08	4.07	0.00	0.27	0.00	0.00	1.08
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	149.14	1.47	3.13	0.18	0.00	0.00	0.00	1.29
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	146.72	1.54	2.63	0.22	0.22	0.00	0.00	1.75
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	95.21	1.98	2.98	0.00	0.00	0.00	0.00	0.00
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	161.86	2.11	3.69	0.40	0.13	0.00	0.00	1.19
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	187.84	2.22	1.41	0.61	0.00	0.00	0.00	1.41
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	136.23	0.76	1.27	0.00	0.00	0.00	0.00	1.02
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	54.94	0.60	2.19	1.00	0.00	0.00	0.00	0.00
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	41.60	0.31	0.92	0.31	0.00	0.00	0.00	0.77
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	48.69	0.41	2.05	0.41	0.00	0.00	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	61.33	0.31	0.94	0.31	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	50.86	0.28	2.54	0.57	0.00	0.00	0.00	0.57
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	37.82	0.92	1.38	0.92	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	49.50	2.47	0.00	2.47	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	52.99	1.16	2.32	0.39	0.00	0.00	0.00	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	38.51	0.00	0.00	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	48.69	0.00	1.74	0.00	0.00	0.00	0.00	1.74
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	55.66	0.65	4.56	0.98	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	61.36	1.24	2.88	1.65	0.00	0.00	0.00	0.82
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	43.32	0.00	6.66	3.33	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	57.61	0.28	1.12	1.40	0.00	0.00	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	53.28	0.33	2.94	1.63	0.00	0.00	0.00	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	47.81	0.00	2.52	0.84	0.00	0.00	0.00	0.84
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	70.29	0.32	4.45	0.64	0.00	0.00	0.00	1.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	64.54	1.70	2.72	1.02	0.00	0.00	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	121.11	2.09	4.18	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	77.31	0.00	2.86	0.57	0.00	0.00	0.00	1.15
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	60.08	0.30	2.37	0.59	0.00	0.00	0.00	1.78
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	94.87	0.00	5.08	1.69	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	84.08	0.83	3.73	2.07	0.00	0.00	0.00	1.66
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	81.01	1.38	1.84	0.69	0.00	0.00	0.00	0.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	57.95	0.00	0.00	0.00	0.00	0.00	0.00	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	77.27	0.38	3.46	0.00	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	82.47	1.63	2.93	0.33	0.00	0.00	0.00	1.96
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	97.65	2.01	3.34	0.67	0.00	0.00	0.00	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	84.76	1.93	2.70	1.93	0.00	0.00	0.00	1.16
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	92.09	0.68	0.68	0.00	0.00	0.00	0.00	0.68
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	74.54	4.97	4.97	2.48	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	84.93	0.47	2.83	1.89	0.00	0.00	0.00	0.47
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	91.73	1.21	1.21	1.21	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	92.58	0.51	4.07	1.02	0.00	0.00	0.00	1.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	93.33	1.20	5.58	0.40	0.00	0.00	0.00	2.39
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	117.42	0.99	4.93	1.97	0.00	0.00	0.00	0.99
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	133.39	2.36	7.08	3.54	0.00	0.00	0.00	4.72
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	103.85	1.75	4.08	2.92	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	97.43	2.63	6.14	0.88	0.00	0.00	0.00	0.44
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	90.70	4.24	3.39	2.54	0.00	0.00	0.00	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	119.38	2.98	2.98	2.39	0.00	0.00	0.00	1.79
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	98.99	0.49	2.43	1.46	0.00	0.00	0.00	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	247.66	1.14	3.42	2.28	0.00	0.00	0.00	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	187.95	2.49	0.83	3.33	0.00	0.00	0.00	2.49
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	191.16	1.12	3.37	0.00	0.00	0.00	0.00	1.12
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	333.02	2.54	1.90	2.85	0.00	0.00	0.00	0.63
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	699.30	6.27	3.34	6.68	0.00	0.00	0.00	1.67
Hep-2 cells mock treated, biol_rep1	11898-125E8	325.03	2.67	4.76	2.55	3.60	0.93	9.17	2.20
Hep-2 cells mock treated, biol_rep2	11899-125E9	346.89	4.39	4.22	2.70	5.06	1.69	9.12	1.01
Hep-2 cells mock treated, biol_rep3	11900-125F1	270.27	3.19	2.28	1.82	3.87	1.14	7.96	3.19
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	319.95	2.73	4.37	2.84	3.94	1.64	7.87	2.73
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	326.67	3.65	2.79	1.50	3.01	1.50	9.03	2.36
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	270.61	2.80	2.58	1.51	2.15	0.86	5.17	1.72
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	318.32	3.11	4.23	1.25	2.62	2.49	8.59	1.87
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	315.82	2.57	2.74	1.89	2.74	1.37	7.89	2.57
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	254.06	0.64	2.88	0.64	3.52	0.96	7.05	1.28
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	248.47	0.56	2.80	0.56	0.56	0.56	0.00	0.00
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	98.24	0.00	1.73	0.00	1.73	1.30	0.00	0.87
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	457.38	21.15	10.58	7.93	0.00	2.64	0.00	5.29
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	109.70	0.35	1.06	0.71	0.00	0.00	0.00	0.71
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	77.74	0.73	0.00	0.00	0.00	0.00	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	385.00	3.85	1.40	3.85	0.35	1.05	0.00	0.52
Hepatocyte, donor1	11523-119I2	87.16	2.42	1.21	2.42	0.00	0.00	0.00	0.00
Hepatocyte, donor2	11603-120I1	166.99	1.08	1.08	1.08	0.00	0.00	0.00	0.00
Hepatocyte, donor3	11684-122I1	152.16	1.84	0.61	0.61	0.00	0.00	0.00	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	72.45	0.65	1.96	0.00	0.00	0.00	0.00	1.31
Intestinal epithelial cells (polarized), donor1	11246-116E4	126.02	1.22	1.22	0.17	0.00	0.00	0.00	0.70
Iris Pigment Epithelial Cells, donor1	11530-119I9	225.16	1.37	1.37	0.41	0.00	0.14	0.00	1.51
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	44.57	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	66.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	35.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	27.53	0.00	0.00	0.00	0.00	2.50	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	38.44	0.00	5.13	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	77.70	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	45.48	0.00	1.62	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	48.35	0.00	1.67	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	39.94	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	41.03	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	62.08	0.00	1.11	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	47.14	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	52.28	0.00	0.63	0.00	0.00	0.00	0.00	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	37.12	0.00	1.55	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	14.63	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	40.70	0.00	0.00	0.00	0.00	0.00	0.00	0.65
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	38.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	23.90	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	39.93	0.00	1.63	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	39.46	0.00	0.42	0.00	0.00	0.00	0.00	0.42
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	48.22	0.00	0.80	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	47.09	0.00	0.00	0.00	0.00	0.92	0.00	1.85
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	30.16	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	48.62	0.00	0.94	0.00	0.00	0.00	0.00	0.47
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	62.58	0.00	0.00	0.91	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	44.23	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	45.20	0.00	0.00	0.00	0.00	0.00	0.00	1.08
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	36.84	0.00	0.00	0.00	0.00	1.27	0.00	2.54
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	49.29	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	42.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	49.21	0.00	3.65	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	41.42	0.00	0.71	0.71	0.00	0.00	0.00	0.71
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	39.82	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	62.55	0.00	0.00	0.00	20.85	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	50.62	0.00	0.31	0.00	0.00	0.00	0.00	0.62
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	45.66	0.00	0.00	0.00	0.00	1.76	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	37.72	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	35.46	0.00	0.70	0.00	0.00	0.00	0.00	2.09
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	37.62	0.00	0.00	0.00	0.00	0.00	0.00	2.21
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	61.60	0.00	3.24	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	33.13	0.00	1.74	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	18.00	0.00	0.00	0.00	0.00	0.00	0.00	2.25
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	55.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	45.87	0.00	2.13	2.13	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	34.64	0.00	1.39	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	34.20	0.00	2.85	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	30.37	0.92	2.76	0.92	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	36.30	0.00	0.00	0.00	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	31.04	0.00	6.21	0.00	0.00	0.00	0.00	6.21
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	22.20	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	264.06	4.41	1.55	0.49	0.16	0.00	0.00	1.14
Keratinocyte - epidermal, donor2	11349-117G8	202.04	0.59	0.59	0.00	0.00	0.00	0.00	0.00
Keratinocyte - epidermal, donor3	11421-118F8	321.74	1.80	1.89	1.04	0.00	0.19	0.00	1.70
Keratinocyte - oral, donor1	11251-116E9	414.45	6.36	2.27	1.02	0.00	0.00	0.00	2.61
Keratocytes, donor1	11527-119I6	82.86	0.00	0.69	0.34	0.00	0.00	0.00	0.69
Keratocytes, donor2	11607-120I5	85.54	0.00	0.00	0.00	0.00	1.17	0.00	2.34
Keratocytes, donor3	11688-122I5	96.43	0.00	2.96	0.79	0.00	0.00	0.00	0.20
Krukenberg tumor cell line:HSKTC	10687-109F3	105.50	4.40	0.00	0.00	0.00	0.00	0.00	2.20
Lens Epithelial Cells, donor1	11529-119I8	204.96	0.00	0.00	1.08	0.00	0.00	0.00	2.16
Lens Epithelial Cells, donor2	11609-120I7	236.20	1.50	2.65	0.23	0.00	0.00	0.00	1.50
Lens Epithelial Cells, donor3	11690-122I7	286.48	0.40	1.61	0.40	0.10	0.10	0.00	0.81
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	1093.75	9.60	4.39	4.51	0.95	0.24	0.00	4.03
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	612.85	12.56	4.19	3.63	0.84	0.84	0.00	1.12
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	829.88	24.08	3.15	5.98	0.16	0.16	0.00	2.99
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	760.33	6.99	2.15	4.84	0.54	0.00	0.00	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	511.83	9.14	1.89	2.21	0.63	0.00	0.00	2.21
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	706.29	16.82	3.67	6.25	0.22	0.11	0.00	3.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	648.01	13.95	4.51	4.51	0.00	0.41	0.00	1.64
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	521.57	6.07	3.54	4.55	1.01	0.25	0.00	1.77
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	653.50	13.51	3.52	5.91	0.56	0.28	0.00	2.25
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	678.34	11.47	1.58	4.35	0.79	1.19	0.40	1.58
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	696.43	9.89	3.68	3.10	0.58	0.78	0.00	1.16
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	557.67	11.29	3.89	4.81	0.19	0.37	0.00	2.22
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	710.09	15.68	2.44	5.23	0.35	0.35	0.00	1.05
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	630.66	9.06	4.29	2.15	0.48	0.24	0.24	0.72
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	622.05	14.56	2.47	4.40	0.27	0.14	0.00	1.65
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	693.83	16.94	3.08	2.77	0.92	0.00	0.31	2.46
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	505.34	7.48	3.43	3.43	0.31	0.31	0.00	0.94
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	605.52	18.30	4.03	2.38	0.55	0.00	0.18	2.74
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	687.51	11.85	4.94	5.59	0.99	0.66	0.00	2.30
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	550.31	5.86	2.93	2.64	0.00	1.17	0.00	1.46
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	494.87	11.95	1.99	4.48	0.00	0.25	0.00	0.75
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	693.01	16.00	3.39	3.88	0.00	0.97	0.00	1.45
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	591.64	8.62	2.96	4.04	1.62	0.81	0.00	3.23
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	736.30	16.95	3.33	7.27	0.15	0.00	0.30	2.27
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	640.76	9.85	4.15	6.74	0.52	0.52	0.52	1.56
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	595.72	8.59	3.77	3.14	0.21	0.84	0.00	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	669.61	15.49	3.76	5.11	0.15	0.15	0.00	1.35
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	696.82	9.63	4.13	6.19	0.00	0.00	0.00	4.13
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	677.71	9.97	2.82	3.01	0.56	0.19	0.19	2.07
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	616.99	13.47	3.29	4.88	0.53	0.21	0.11	1.27
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	627.53	9.69	3.39	1.94	0.97	0.97	0.00	2.42
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	535.55	6.95	2.65	2.32	0.33	0.33	0.00	0.99
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	653.28	13.38	3.59	4.71	0.25	0.62	0.00	1.86
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	1006.23	16.29	6.66	4.07	0.37	0.74	0.00	2.22
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	620.92	9.39	2.72	2.72	0.25	0.74	0.00	1.73
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	587.92	12.37	4.26	3.99	0.27	0.14	0.00	2.06
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	764.53	16.40	2.57	7.08	0.64	0.32	0.00	1.61
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	642.14	10.35	2.13	1.22	0.61	1.52	0.00	1.83
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	779.05	15.82	4.76	4.20	0.42	0.00	0.00	1.82
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	733.88	16.00	6.40	4.27	0.71	0.36	0.00	1.07
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	473.63	6.79	2.91	1.45	0.97	1.45	0.48	0.00
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	512.42	10.89	2.80	4.05	0.31	0.16	0.16	2.49
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	770.64	8.59	5.37	2.86	0.72	0.36	0.00	3.94
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	508.96	7.19	2.61	4.57	0.33	0.00	0.00	1.96
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	554.66	15.07	3.06	4.47	0.00	0.00	0.00	2.35
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	933.33	6.56	3.84	3.47	0.50	0.62	0.00	1.98
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	401.61	3.33	3.07	2.05	1.28	0.51	0.00	0.26
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	658.77	5.97	2.09	4.48	0.30	0.30	0.00	1.49
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	129.16	0.00	2.27	0.00	0.00	0.00	0.00	2.27
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	97.43	0.00	0.00	0.77	0.00	0.00	0.77	0.77
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	98.72	1.48	1.48	0.74	0.00	0.74	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	78.28	1.69	0.42	0.85	0.00	0.00	0.85	0.42
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	111.83	1.41	0.70	0.70	0.00	0.70	1.41	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	93.40	1.87	0.93	0.00	0.00	0.00	0.00	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	77.81	1.03	0.52	2.58	0.00	0.00	0.00	0.52
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	107.05	0.00	0.00	0.00	1.19	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	137.30	0.00	0.68	0.45	0.00	0.68	0.45	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	117.49	1.16	1.74	1.45	0.00	0.00	0.29	0.29
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	110.29	1.80	0.45	2.70	0.00	0.00	0.90	0.00
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	128.71	0.81	0.54	0.41	0.14	0.27	0.27	0.27
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	95.52	1.54	0.00	0.00	0.00	0.51	0.51	0.51
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	117.50	1.41	0.35	0.71	0.35	0.00	0.71	0.35
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	107.94	0.67	0.00	2.67	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	92.71	1.53	0.51	0.51	0.00	0.51	1.02	0.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	125.67	0.27	1.87	0.00	0.27	0.53	0.53	0.53
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	130.37	2.27	1.13	1.51	0.19	0.19	0.00	0.57
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	87.74	1.84	0.61	0.61	0.00	0.00	0.00	0.61
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	101.93	0.00	1.63	1.63	0.00	0.82	0.82	0.82
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	117.24	1.87	0.62	0.83	0.21	0.42	0.83	0.62
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	117.43	2.24	1.96	1.68	0.00	0.28	0.84	0.28
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	93.76	0.00	0.00	0.00	0.00	0.00	2.06	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	126.57	1.74	0.87	1.74	0.29	0.29	1.16	0.58
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	117.48	2.99	0.90	1.49	0.60	0.00	0.30	0.90
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	125.04	2.21	0.55	1.66	0.00	0.00	0.55	1.11
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	93.67	1.41	0.35	0.71	0.00	0.35	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	106.58	0.74	0.37	2.21	0.00	0.37	0.00	0.37
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	115.13	0.00	1.15	0.00	0.00	0.00	1.15	0.00
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	113.21	0.77	0.77	1.15	0.00	0.77	0.00	0.38
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	91.15	2.26	0.00	0.00	0.00	0.57	0.00	1.13
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	120.61	1.64	1.64	2.46	0.82	0.00	0.82	0.00
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	101.22	0.45	1.36	2.26	0.00	0.45	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	116.34	0.72	0.00	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	129.21	0.00	2.24	0.75	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	91.78	1.11	1.49	1.49	0.00	0.00	0.37	0.37
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	118.46	3.02	0.43	0.86	0.00	0.00	0.00	0.43
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	103.61	0.86	1.71	0.86	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	110.28	2.33	1.33	1.00	0.00	1.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	91.10	2.41	0.60	1.21	0.00	0.60	0.00	0.60
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	93.85	0.00	1.42	0.00	0.00	0.00	0.71	0.00
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	106.21	1.37	0.34	1.03	0.00	0.69	0.00	0.34
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	109.50	1.07	1.07	1.07	0.00	0.54	0.54	1.07
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	101.00	0.00	0.67	1.35	0.00	0.00	0.00	0.67
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	108.16	1.48	1.48	0.00	0.00	0.37	0.37	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	123.27	0.00	1.16	0.00	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	108.95	0.00	0.00	2.12	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	102.04	2.40	1.20	2.40	0.00	0.00	0.80	0.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	92.31	2.18	0.00	0.00	0.73	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	118.04	0.77	3.07	0.00	0.00	0.00	0.77	0.00
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	111.97	1.48	1.48	0.99	0.00	0.00	0.99	0.00
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	73.39	0.00	0.94	2.82	0.00	0.00	0.94	0.94
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	98.05	1.01	2.51	0.50	0.00	0.00	0.50	2.01
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	99.14	0.90	0.45	0.00	0.00	0.00	0.45	0.45
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	70.57	0.00	1.72	3.44	0.00	0.00	0.00	5.16
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	110.00	0.00	0.45	1.78	0.45	0.00	0.00	1.34
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	93.85	1.56	0.78	0.78	0.39	1.17	0.78	0.39
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	89.72	1.98	0.66	1.32	0.00	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	128.69	3.11	1.04	1.04	0.52	0.00	0.52	0.00
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	96.26	0.00	1.31	0.44	0.00	0.00	0.00	0.44
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	96.72	1.12	1.12	1.12	0.00	1.12	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	113.06	0.00	0.44	0.44	0.00	0.44	0.44	0.00
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	122.27	2.31	0.77	0.77	0.00	0.00	0.39	0.39
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	107.35	3.54	1.52	1.01	0.00	1.01	0.00	1.01
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	117.27	1.44	1.44	0.48	0.96	0.96	0.00	0.00
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	104.16	1.19	0.80	1.59	0.00	0.40	0.80	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	102.69	3.65	1.82	0.00	0.00	0.00	0.61	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	87.15	2.77	0.69	1.38	0.69	0.69	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	102.98	0.00	0.00	1.14	0.00	0.38	0.00	0.38
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	112.58	1.55	0.52	1.03	0.00	0.00	1.55	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	75.58	1.21	1.81	0.60	0.60	0.60	0.00	0.00
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	109.65	0.32	0.63	0.32	0.00	0.32	0.32	0.32
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	107.68	0.53	2.67	0.00	0.53	0.53	0.53	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	85.05	1.15	0.57	0.00	0.00	0.57	0.00	0.00
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	102.85	2.06	0.51	2.57	0.00	1.03	0.00	0.51
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	113.88	2.12	0.71	1.41	0.00	0.71	0.00	1.41
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	92.50	1.13	1.13	1.13	0.00	0.57	0.57	0.00
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	111.08	0.83	1.25	1.25	0.00	0.83	0.42	0.42
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	109.63	2.35	0.00	1.57	0.00	0.00	1.57	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	96.45	0.42	0.42	0.00	0.42	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	112.44	1.39	1.86	1.39	0.00	0.00	0.46	0.46
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	93.00	0.67	1.34	0.00	1.34	1.34	0.00	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	80.73	0.00	0.53	1.07	0.00	0.00	1.07	0.00
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	113.96	1.21	1.21	0.40	0.00	0.40	0.00	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	77.09	3.67	0.92	0.92	0.00	0.92	0.92	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	78.24	0.00	0.89	2.67	0.00	0.00	0.89	0.00
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	92.32	0.00	1.14	0.00	0.00	0.57	2.28	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	93.56	0.77	0.00	1.53	1.53	0.00	0.00	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	85.91	0.55	1.64	1.09	0.00	1.09	0.55	0.00
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	118.93	0.00	1.34	0.89	0.00	0.45	0.45	0.89
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	145.31	1.04	0.52	1.82	0.26	0.26	0.00	0.52
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	96.15	0.66	0.00	1.99	0.00	0.66	0.00	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	108.09	2.08	0.00	4.16	0.00	0.00	0.00	0.00
Macrophage - monocyte derived, donor1	11232-116C8	624.49	8.43	5.01	1.37	1.37	1.14	0.00	2.73
Macrophage - monocyte derived, donor2	11313-117C8	290.12	1.84	1.10	1.28	2.75	4.22	0.00	2.39
Macrophage - monocyte derived, donor3	11389-118C3	288.64	4.19	3.67	0.92	1.97	1.44	0.00	2.36
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	695.11	2.66	3.19	1.59	2.12	1.59	0.00	3.72
Mallassez-derived cells, donor2	11929-125I3	874.50	3.96	3.33	0.63	0.48	0.48	0.00	2.85
Mallassez-derived cells, donor3	11930-125I4	593.48	3.06	3.61	1.53	0.42	0.00	0.00	1.95
Mammary Epithelial Cell, donor1	11273-116H4	827.04	12.75	5.48	1.00	0.30	0.40	0.20	2.99
Mammary Epithelial Cell, donor2	11350-117G9	680.15	4.34	2.32	2.03	1.16	0.58	0.00	2.61
Mammary Epithelial Cell, donor3	11422-118F9	202.29	0.50	2.74	2.00	0.25	0.00	0.00	1.25
Mast cell - stimulated, donor1	11487-119E2	300.33	0.68	0.68	0.68	0.68	2.03	0.00	0.00
Mast cell, donor1	11563-120D6	275.54	2.60	2.05	0.43	0.22	0.43	0.00	1.73
Mast cell, donor2	11565-120D8	147.70	0.59	4.46	0.59	0.00	0.30	0.00	2.08
Mast cell, donor3	11566-120D9	155.34	1.58	9.23	0.00	0.00	0.23	0.00	2.48
Mast cell, donor4	11567-120E1	188.64	3.19	4.96	0.35	0.00	0.00	0.18	1.42
Mast cell, expanded and stimulated, donor5	11940-126A5	304.62	1.00	1.33	0.78	1.66	2.00	0.00	2.22
Mast cell, expanded and stimulated, donor8	11942-126A7	188.53	3.50	0.58	0.00	1.17	5.25	0.00	1.75
Mast cell, expanded, donor5	11939-126A4	371.47	2.64	5.28	1.38	0.00	0.46	0.00	2.87
Mast cell, expanded, donor8	11941-126A6	206.87	2.01	2.51	0.50	0.00	0.50	0.17	2.01
Melanocyte - dark, donor1	11502-119F8	516.00	3.38	2.19	0.40	0.30	0.10	0.00	2.79
Melanocyte - dark, donor2	11582-120F7	354.73	2.08	1.38	2.42	1.04	0.69	0.00	0.69
Melanocyte - dark, donor3	11663-122F7	692.53	6.45	2.25	0.65	1.01	1.09	0.07	2.32
Melanocyte - light, donor1	11274-116H5	223.79	0.47	1.41	0.94	0.47	0.00	0.00	1.41
Melanocyte - light, donor2	11351-117H1	255.24	0.00	0.68	1.36	0.00	0.00	0.00	0.68
Melanocyte - light, donor3	11423-118G1	149.16	0.87	0.00	0.00	0.87	0.87	0.00	2.60
Melanocyte, donor1 (MC+1)	12641-134G4	583.73	3.33	1.35	2.50	0.52	0.31	0.00	1.67
Melanocyte, donor2 (MC+2)	12739-135I3	523.90	14.25	2.42	3.23	0.27	0.00	0.27	1.61
Melanocyte, donor3 (MC+3)	12837-137B2	463.66	6.96	2.41	2.14	0.00	0.00	0.00	2.41
Meningeal Cells, donor1	11493-119E8	240.30	0.87	1.49	0.25	0.25	0.12	0.00	1.36
Meningeal Cells, donor2	11573-120E7	155.37	0.44	3.08	0.00	0.00	0.00	0.00	0.88
Meningeal Cells, donor3	11654-122E7	593.33	5.71	2.69	0.65	1.14	1.14	0.00	2.61
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	771.06	5.70	5.70	2.28	0.29	0.00	0.00	5.13
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	419.13	2.31	1.91	0.50	0.00	0.00	0.00	1.21
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	23.65	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	74.57	0.00	0.00	0.00	1.31	0.00	0.00	1.31
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	756.36	6.46	1.44	5.74	7.89	7.18	0.00	3.59
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	343.70	1.91	0.64	0.64	0.00	0.21	0.00	1.91
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	258.86	4.02	2.01	0.00	0.00	0.00	0.00	0.50
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	235.36	0.88	2.20	0.44	0.66	0.22	0.00	0.44
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	252.05	1.46	1.46	0.73	0.00	0.00	0.00	4.38
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	223.43	1.23	2.86	0.82	0.61	0.41	0.00	1.64
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	357.49	1.39	1.52	1.11	0.00	0.28	0.00	0.97
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	80.66	0.37	0.74	0.37	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	262.62	4.47	1.18	0.66	0.00	0.00	0.00	0.26
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	77.75	0.30	1.19	0.00	0.00	0.00	0.00	0.30
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	25.69	2.34	0.00	0.00	0.00	0.00	0.00	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	94.78	0.00	1.28	0.64	0.00	0.00	0.00	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	1069.71	4.96	5.32	6.73	7.44	10.28	0.35	2.13
Mesenchymal stem cells - hepatic, donor0	11218-116B3	301.15	2.81	1.56	0.63	0.00	0.00	0.31	0.94
Mesenchymal stem cells - umbilical, donor0	11214-116A8	380.26	2.18	0.73	1.45	0.00	0.00	0.00	3.63
Mesothelial Cells, donor1	11247-116E5	429.05	5.30	1.86	1.59	0.00	0.00	0.00	2.12
Mesothelial Cells, donor2	12156-128G5	388.36	0.00	2.00	0.00	0.00	0.00	0.00	1.50
Mesothelial Cells, donor3	11402-118D7	229.95	2.53	1.30	0.87	0.00	0.00	0.00	0.51
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	141.78	2.70	1.35	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	372.61	4.43	3.20	1.97	2.96	4.68	0.00	1.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	280.32	2.36	2.06	0.59	2.36	3.83	0.00	2.36
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	41.48	0.00	3.46	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	386.50	6.51	1.86	1.55	3.10	2.17	0.00	1.55
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	272.36	4.15	1.66	0.62	2.07	2.49	0.21	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	34.74	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	438.71	7.76	2.50	2.00	2.50	2.75	0.25	3.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	210.40	2.33	2.33	0.47	1.86	1.40	0.00	1.86
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	384.08	6.30	1.63	1.83	3.45	3.25	0.00	2.03
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	228.47	5.15	0.79	0.00	4.36	5.54	0.00	2.38
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	8.55	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	409.73	6.19	0.88	2.65	0.88	1.77	0.00	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	351.44	4.18	2.28	0.76	1.52	4.94	0.38	2.28
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	26.32	1.32	1.32	0.00	0.00	1.32	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	401.10	6.79	2.33	1.70	2.33	3.18	0.00	1.06
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	86.56	0.00	0.92	0.00	0.92	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	253.05	4.77	1.19	0.60	1.19	1.79	0.00	1.49
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	75.45	0.00	1.68	0.00	0.00	0.00	0.00	1.68
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	385.64	7.03	2.01	2.26	4.01	2.51	0.00	2.26
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	200.59	4.52	1.66	0.71	1.66	2.14	0.00	1.19
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	46.44	1.66	0.55	0.00	0.00	0.00	0.00	0.55
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	443.45	3.45	1.38	0.69	2.07	5.30	0.00	2.99
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	249.88	2.10	1.26	1.26	2.52	2.73	0.00	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	221.77	1.43	1.02	0.82	4.08	1.02	0.00	1.43
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	525.41	7.29	1.50	1.50	4.08	3.86	0.21	0.86
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	167.16	3.33	2.00	0.89	2.67	3.56	0.00	0.67
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	20.64	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	333.34	6.57	1.10	1.53	2.63	3.07	0.22	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	100.38	0.51	1.01	0.51	0.00	1.01	0.00	1.01
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	34.80	0.00	0.00	0.00	0.00	1.66	0.00	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	319.36	4.89	0.54	3.53	2.17	2.72	0.00	1.36
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	194.68	2.06	1.76	0.59	2.35	2.06	0.00	2.06
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	39.25	0.00	3.27	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	395.50	6.25	0.96	2.88	4.32	2.88	0.00	0.96
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	232.13	2.80	2.00	0.80	0.40	3.60	0.00	0.40
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	61.70	1.37	0.00	0.00	1.37	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	413.98	2.00	2.50	2.00	2.00	5.01	0.50	1.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	242.52	26.95	0.00	53.89	0.00	26.95	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	61.16	0.00	2.04	0.00	0.00	4.08	0.00	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	414.71	3.07	1.31	2.19	3.50	3.94	0.00	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	70.63	2.21	2.21	0.00	0.00	1.10	0.00	2.21
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	73.64	0.00	5.12	0.00	0.00	1.28	0.00	0.64
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	459.89	3.97	3.97	2.73	2.48	6.69	0.00	1.98
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	133.61	2.78	2.78	0.00	0.70	0.70	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	57.46	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	406.15	2.74	2.39	1.71	1.71	5.47	0.00	2.39
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	123.41	0.44	3.94	0.00	0.88	1.31	0.00	0.88
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	64.63	0.36	1.07	0.00	0.00	0.71	0.00	0.36
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	433.45	1.68	2.81	1.12	2.24	4.77	0.28	3.09
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	182.88	0.42	4.16	0.83	0.42	1.25	0.00	1.66
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	55.94	0.00	2.91	0.00	0.00	0.00	0.00	1.75
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	261.54	2.11	3.02	0.60	1.51	4.83	0.00	1.21
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	303.44	1.67	2.09	1.67	3.76	4.17	0.00	2.92
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	57.75	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	247.51	1.85	0.92	1.85	1.85	6.46	0.00	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	233.34	0.00	1.14	2.28	2.28	3.41	0.00	1.14
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	118.70	0.14	0.97	0.28	0.28	0.55	0.28	1.66
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	305.28	1.04	2.33	1.04	2.07	3.89	0.00	2.07
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	218.35	0.00	3.86	0.86	0.43	3.00	0.00	3.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	57.17	0.00	2.54	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	164.40	0.53	1.33	0.80	0.53	2.14	0.00	2.14
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	308.01	0.60	2.39	0.90	2.69	2.99	0.00	1.20
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	88.00	0.14	1.27	0.14	0.14	0.42	0.00	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	285.39	0.64	1.27	1.27	2.55	3.19	0.00	1.27
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	294.32	0.22	2.65	0.88	1.11	4.64	0.00	2.21
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	72.81	0.00	1.90	0.38	0.00	0.76	0.00	1.90
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	273.03	1.70	2.56	1.70	1.70	2.56	0.00	1.70
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	350.27	0.00	1.97	1.47	2.95	4.67	0.00	2.21
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	54.74	0.65	0.65	0.00	0.00	0.00	0.00	1.30
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	193.18	1.18	1.47	0.88	0.29	1.47	0.00	1.76
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	298.13	1.44	2.88	1.15	1.44	3.17	0.00	2.59
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	125.70	1.24	0.82	0.41	0.41	0.82	0.00	1.65
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	159.02	0.30	4.17	0.89	0.60	1.19	0.00	1.49
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	674.27	11.30	0.00	3.77	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	782.41	14.26	5.35	7.13	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	548.06	6.90	6.90	0.99	0.33	0.00	0.00	2.63
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	370.29	10.52	3.16	2.10	0.00	1.05	0.00	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	702.58	10.08	4.74	3.95	0.59	0.40	0.00	2.77
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	438.65	5.59	3.73	0.93	1.86	0.93	0.00	1.86
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	612.86	10.51	6.01	3.00	0.38	0.00	0.00	3.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	352.10	2.93	3.20	1.07	2.66	3.46	0.27	1.86
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	527.84	2.49	3.73	1.58	0.23	0.23	0.00	2.26
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	531.18	9.58	2.21	3.68	1.47	0.00	0.00	2.21
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	490.28	10.99	6.60	1.83	0.00	0.73	0.00	2.20
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	340.68	6.22	3.11	7.78	6.22	0.00	0.00	1.56
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	549.40	0.53	1.60	1.07	0.00	1.07	0.00	3.21
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	606.63	3.86	3.86	15.46	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	521.13	8.08	7.07	1.01	0.00	0.00	1.01	1.01
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	255.94	0.84	2.11	0.84	0.84	0.42	0.00	0.42
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	614.24	0.00	1.36	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	837.34	0.00	1.27	3.81	0.00	0.64	0.00	3.18
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	806.60	0.00	3.24	3.24	0.81	0.81	0.00	5.67
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	305.11	0.00	0.00	0.00	0.00	1.51	0.00	1.51
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	314.06	0.00	0.00	0.00	0.00	5.71	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	580.72	0.00	6.52	3.26	6.52	0.00	0.00	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	213.86	0.00	0.00	4.75	4.75	0.00	0.00	9.50
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	238.43	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	866.05	2.59	3.45	1.94	1.94	1.51	0.00	3.02
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	290.57	3.14	3.66	0.52	0.52	1.05	0.00	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	353.77	0.67	2.00	0.67	0.00	1.33	0.00	2.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	517.12	3.76	3.76	0.83	0.00	0.42	0.00	2.09
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	1026.00	2.47	7.42	2.66	0.57	2.09	0.00	7.04
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	473.97	1.60	4.79	1.60	0.00	0.00	0.00	1.60
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	352.21	4.08	4.76	3.40	0.00	0.00	0.00	2.04
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	683.60	55.13	5.51	7.35	0.00	0.00	0.00	5.51
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	246.94	0.84	0.42	2.51	0.00	0.00	0.00	1.67
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	786.11	2.32	6.51	1.86	0.00	0.23	0.00	3.72
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	284.01	0.81	5.40	0.81	0.00	0.00	0.00	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	240.51	1.47	1.89	0.84	0.00	0.00	0.00	2.52
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	1202.55	167.02	0.00	33.40	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	472.53	0.50	4.47	3.97	0.00	0.00	0.00	2.98
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	268.50	3.25	4.33	0.81	0.00	0.00	0.00	0.81
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	496.89	3.85	2.27	0.91	0.23	0.00	0.00	2.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	222.25	0.98	4.41	0.82	0.00	0.00	0.00	1.63
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	248.05	2.55	2.37	2.37	0.00	0.00	0.00	1.09
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	397.30	0.53	3.18	4.77	0.00	0.00	0.00	0.53
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	281.54	3.00	1.80	1.20	0.00	0.00	0.00	1.20
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	376.09	3.61	4.27	0.33	0.00	0.00	0.00	2.95
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	333.38	1.46	3.25	1.63	0.16	0.16	0.00	1.95
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	174.27	1.23	3.53	1.76	0.00	0.00	0.00	0.53
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	286.92	2.11	4.22	1.41	0.00	0.00	0.00	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	272.61	2.30	5.06	2.76	0.00	0.00	0.00	3.22
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	223.98	0.96	2.89	1.29	0.00	0.00	0.00	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	692.54	4.83	4.14	2.07	0.00	0.00	0.00	5.52
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	288.24	12.64	7.59	2.53	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	139.46	0.89	2.45	1.11	0.22	0.00	0.00	1.56
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	239.22	2.12	1.69	0.00	0.00	0.00	0.00	1.27
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	377.15	1.66	6.65	0.24	0.24	0.00	0.24	2.37
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	201.75	0.43	1.29	1.72	0.43	0.00	0.00	2.15
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	668.05	81.25	0.00	0.00	0.00	0.00	0.00	9.03
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	212.60	0.00	3.00	1.00	0.00	0.00	0.00	1.67
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	73.49	0.90	1.80	0.00	0.00	0.00	0.00	0.90
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	181.34	0.79	0.79	2.38	0.00	0.79	0.00	1.19
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	299.95	0.93	0.00	0.93	0.00	0.93	0.00	0.93
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	303.45	1.51	2.65	1.89	0.00	0.00	0.00	4.54
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	215.08	1.30	1.30	1.96	0.33	0.33	0.00	0.98
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	150.35	0.87	1.31	0.44	0.00	0.00	0.00	0.44
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	126.64	1.36	1.36	0.45	0.45	0.90	0.00	1.36
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	182.56	0.00	0.88	1.76	0.00	0.00	0.00	1.76
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	251.98	2.66	1.99	2.66	0.00	0.66	0.00	1.99
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	210.82	1.98	2.98	1.98	0.00	0.00	0.00	1.49
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	161.94	0.77	1.15	1.15	0.00	0.00	0.00	0.77
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	590.07	2.42	2.12	2.12	0.00	0.00	0.00	3.33
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	148.97	1.55	1.33	0.44	0.00	0.22	0.00	1.11
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	155.18	0.68	4.74	2.03	0.68	0.68	0.00	0.00
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	373.00	20.44	0.00	10.22	0.00	0.00	0.00	5.11
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	235.34	0.61	3.66	1.22	0.00	0.00	0.00	1.22
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	151.70	1.26	3.15	0.31	0.00	0.00	0.00	0.63
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	227.29	0.30	3.33	0.61	0.00	0.00	0.00	0.91
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	174.05	0.79	3.16	3.96	0.00	0.00	0.00	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	362.77	6.80	2.27	4.53	2.27	1.13	0.00	5.67
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	475.44	35.41	0.00	0.00	0.00	0.00	0.00	0.00
Myoblast, donor1	11241-116D8	1077.93	8.57	4.47	5.84	1.37	1.37	0.25	3.23
Myoblast, donor2	11322-117D8	709.23	5.56	3.26	5.56	0.58	0.38	0.00	2.88
Myoblast, donor3	11398-118D3	835.77	2.86	5.55	1.35	1.51	1.35	0.00	3.53
NK T cell leukemia cell line:KHYG-1	10777-110G3	28.02	0.29	2.33	0.15	0.00	0.00	0.00	0.44
Natural Killer Cells, donor1	11230-116C6	22.45	0.62	1.23	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor2	11311-117C6	17.19	0.30	0.90	0.00	0.00	0.00	0.00	0.00
Natural Killer Cells, donor3	11387-118C1	19.51	0.92	0.74	0.55	0.00	0.18	0.00	0.18
Neural stem cells, donor1	11275-116H6	250.07	1.09	3.63	0.36	0.73	0.00	0.00	1.45
Neural stem cells, donor2	11352-117H2	150.20	0.00	9.63	0.00	0.00	0.00	0.00	0.00
Neurons, donor1	11494-119E9	133.13	0.00	0.00	3.41	0.00	2.28	0.00	2.28
Neurons, donor2	11574-120E8	191.32	1.54	2.86	0.88	0.22	0.22	0.00	1.10
Neurons, donor3	11655-122E8	147.17	0.82	0.00	4.11	0.00	0.00	0.00	1.64
Neutrophils, donor1	11233-116C9	51.04	0.93	1.86	0.93	0.00	0.00	0.00	0.00
Neutrophils, donor2	11314-117C9	23.19	0.00	2.90	0.00	0.00	0.00	0.00	0.00
Neutrophils, donor3	11390-118C4	123.39	0.61	2.44	0.00	0.00	0.00	0.00	0.61
Nucleus Pulposus Cell, donor1	11252-116F1	320.70	3.44	2.97	1.07	0.24	0.00	0.00	1.31
Nucleus Pulposus Cell, donor2	11409-118E5	256.58	0.00	4.56	2.28	0.00	0.33	0.00	1.30
Nucleus Pulposus Cell, donor3	11462-119B4	309.05	1.00	2.01	0.80	0.00	0.00	0.00	0.60
Olfactory epithelial cells, donor1	11933-125I7	252.32	8.81	2.62	2.34	0.14	0.41	0.14	2.06
Olfactory epithelial cells, donor2	11934-125I8	424.83	6.37	2.61	7.67	0.43	0.14	0.00	1.88
Olfactory epithelial cells, donor3	11935-125I9	248.92	5.56	1.70	1.93	0.11	0.23	0.11	1.25
Olfactory epithelial cells, donor4	11936-126A1	350.82	4.19	2.05	1.75	0.00	0.00	0.00	1.56
Oligodendrocyte - precursors, donor1	11496-119F2	540.43	4.81	5.42	1.20	0.00	0.00	0.00	1.81
Osteoblast - differentiated, donor1	11276-116H7	429.43	1.49	1.91	0.64	0.00	0.00	0.00	1.49
Osteoblast - differentiated, donor2	11353-117H3	342.93	2.29	1.14	3.43	0.00	0.00	0.00	0.00
Osteoblast - differentiated, donor3	11425-118G3	222.83	1.24	0.62	1.24	0.00	0.00	0.00	0.00
Osteoblast, donor1	11277-116H8	315.44	1.76	1.17	1.17	0.00	0.00	0.00	1.17
Osteoblast, donor2	11354-117H4	619.44	0.70	4.21	2.11	0.00	0.00	0.00	2.11
Osteoblast, donor3	11426-118G4	366.84	0.71	3.20	0.71	0.00	0.89	0.00	1.42
Pancreatic stromal cells, donor1	11249-116E7	438.11	3.29	2.36	1.94	0.08	0.08	0.00	2.27
Pericytes, donor1	11491-119E6	53.63	0.33	0.67	0.00	0.00	0.11	0.00	0.22
Pericytes, donor2	11571-120E5	49.57	0.45	0.23	0.00	0.00	0.00	0.00	0.68
Pericytes, donor3	11652-122E5	276.28	3.26	2.24	1.42	0.20	0.41	0.20	0.61
Perineurial Cells, donor1	11499-119F5	878.06	9.38	2.94	1.36	0.68	0.45	0.00	3.16
Perineurial Cells, donor2	11579-120F4	390.77	0.64	1.38	0.74	0.46	0.74	0.00	1.56
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	23.27	0.32	0.64	0.00	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	8.57	0.49	0.49	0.49	0.00	0.00	0.00	0.00
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	11.00	0.13	0.52	0.00	0.00	0.00	0.00	0.00
Placental Epithelial Cells, donor1	11278-116H9	919.12	3.35	3.35	2.39	2.63	1.43	0.48	1.67
Placental Epithelial Cells, donor2	11355-117H5	929.25	4.44	2.22	0.00	3.33	2.22	1.11	2.22
Placental Epithelial Cells, donor3	11427-118G5	590.94	1.37	2.75	3.34	3.53	1.96	0.79	0.79
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	619.30	3.48	1.90	9.49	0.63	0.95	0.32	0.63
Preadipocyte - breast, donor1	11467-119B9	569.52	4.31	1.88	1.13	0.56	0.38	0.00	1.69
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	385.19	2.22	0.39	0.39	0.26	0.52	0.00	0.65
Preadipocyte - breast, donor2	11328-117E5	413.60	3.38	2.03	2.48	0.90	0.23	0.00	2.70
Preadipocyte - omental, donor1	11468-119C1	694.23	4.05	1.92	1.70	0.00	0.85	0.00	1.81
Preadipocyte - omental, donor2	11329-117E6	666.05	6.11	2.62	2.18	0.00	0.00	0.00	0.87
Preadipocyte - omental, donor3	11403-118D8	526.73	4.87	2.29	1.58	0.43	0.43	0.00	1.00
Preadipocyte - perirenal, donor1	11469-119C2	630.92	2.95	3.94	0.98	0.00	0.98	0.00	1.97
Preadipocyte - subcutaneous, donor1	11279-116I1	238.32	0.92	1.84	0.31	0.31	0.61	0.00	1.54
Preadipocyte - subcutaneous, donor2	11356-117H6	389.75	1.95	2.83	3.36	0.71	0.89	0.00	1.42
Preadipocyte - subcutaneous, donor3	11428-118G6	514.26	2.38	1.87	2.21	0.34	0.17	0.00	1.70
Preadipocyte - visceral, donor1	11280-116I2	483.90	3.17	2.70	0.84	0.19	0.47	0.00	3.26
Preadipocyte - visceral, donor2	11357-117H7	350.66	4.60	1.38	1.84	0.92	0.00	0.00	3.22
Preadipocyte - visceral, donor3	11429-118G7	426.53	3.34	1.99	3.76	0.73	0.42	0.00	1.57
Prostate Epithelial Cells (polarized), donor1	11253-116F2	101.07	0.75	1.06	0.45	0.00	0.00	0.00	0.15
Prostate Epithelial Cells, donor2	11331-117E8	428.31	5.28	3.25	3.93	0.41	0.27	0.14	1.22
Prostate Epithelial Cells, donor3	11404-118D9	166.93	1.53	0.92	0.31	0.06	0.00	0.00	0.37
Prostate Stromal Cells, donor1	11254-116F3	309.70	1.48	1.82	1.14	0.00	0.23	0.00	2.05
Prostate Stromal Cells, donor2	11332-117E9	264.82	2.51	2.33	1.61	0.18	0.18	0.00	1.61
Prostate Stromal Cells, donor3	11405-118E1	312.20	1.56	3.75	2.40	0.10	0.10	0.00	1.46
Renal Cortical Epithelial Cells, donor1	11516-119H4	171.91	0.36	1.82	0.36	0.00	0.00	0.00	0.36
Renal Cortical Epithelial Cells, donor2	11596-120H3	582.36	6.45	1.46	1.73	0.14	0.49	0.00	1.25
Renal Epithelial Cells, donor1	11517-119H5	59.85	0.00	1.01	0.00	0.00	0.00	0.00	0.51
Renal Epithelial Cells, donor2	11597-120H4	132.31	0.71	0.71	1.42	0.00	0.71	0.00	2.13
Renal Epithelial Cells, donor3	11678-122H4	625.34	5.19	1.91	1.91	0.00	0.42	0.00	2.01
Renal Glomerular Endothelial Cells, donor1	11514-119H2	189.28	0.68	2.72	2.04	0.68	0.68	0.00	0.68
Renal Glomerular Endothelial Cells, donor2	11594-120H1	535.15	5.79	1.75	3.50	2.02	2.16	0.13	1.62
Renal Glomerular Endothelial Cells, donor3	11675-122H1	486.87	2.66	1.55	3.11	1.33	1.78	0.00	2.22
Renal Glomerular Endothelial Cells, donor4	11783-124B1	75.20	0.67	2.66	0.00	0.67	0.00	0.00	0.00
Renal Mesangial Cells, donor1	11518-119H6	148.78	0.66	0.66	0.44	0.00	0.00	0.00	0.88
Renal Mesangial Cells, donor2	11598-120H5	112.23	1.25	0.00	0.00	0.00	0.00	0.00	0.00
Renal Mesangial Cells, donor3	11679-122H5	55.48	0.55	0.55	0.28	0.00	0.00	0.00	0.28
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	228.96	0.81	1.61	0.00	0.27	0.00	0.00	1.34
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	115.97	0.00	1.69	0.00	0.42	0.00	0.00	1.27
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	108.96	0.77	1.74	0.19	0.00	0.00	0.00	0.58
Retinal Pigment Epithelial Cells, donor0	11215-116A9	134.83	1.81	1.81	0.52	0.00	0.00	0.00	1.81
Retinal Pigment Epithelial Cells, donor1	11528-119I7	92.66	0.57	1.71	0.00	0.00	0.00	0.00	0.85
Retinal Pigment Epithelial Cells, donor2	11608-120I6	32.93	0.00	1.03	0.00	0.00	0.00	0.00	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	65.49	1.51	0.25	0.25	0.00	0.00	0.00	0.25
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	526.26	11.23	1.87	1.60	12.29	6.55	15.77	2.67
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	69.69	0.00	0.89	0.00	0.00	0.00	0.00	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	117.78	0.00	1.65	0.00	0.00	0.00	0.00	1.10
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	64.39	0.00	0.00	0.00	0.00	0.00	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	73.20	0.52	1.82	0.00	0.26	0.52	0.00	0.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	60.87	0.30	1.59	0.79	0.20	0.20	0.00	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	109.42	1.00	2.45	0.33	0.89	0.33	0.00	1.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	114.62	1.12	1.61	0.87	0.99	0.50	0.00	1.12
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	67.71	0.35	1.75	0.47	0.58	0.23	0.00	1.05
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	85.98	0.46	2.08	0.69	0.69	0.23	0.00	0.69
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	59.97	0.14	1.23	0.41	0.55	0.14	0.14	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	69.43	0.45	0.91	0.15	0.91	0.45	0.00	0.61
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	94.43	0.72	2.15	0.54	0.00	0.36	0.00	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	67.57	0.29	0.86	0.00	0.29	0.29	0.00	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	75.76	0.11	1.07	0.21	0.32	0.11	0.00	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	76.12	0.22	1.55	1.11	0.44	0.66	0.00	0.89
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	54.87	0.00	0.76	0.00	0.00	0.38	0.00	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	61.77	0.47	1.12	0.56	0.75	0.37	0.00	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	91.70	0.56	1.32	0.00	0.00	0.19	0.00	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	50.16	0.13	1.33	0.00	0.27	0.00	0.00	0.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	62.69	0.10	1.07	0.39	0.58	0.58	0.00	0.58
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	71.04	0.19	1.34	0.57	0.76	0.95	0.00	0.38
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	57.35	0.00	1.92	0.11	0.96	0.21	0.11	0.64
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	65.59	1.12	0.00	1.12	0.28	0.00	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	67.50	0.34	1.54	1.37	0.51	0.17	0.00	0.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	52.15	0.00	1.28	0.00	0.55	0.73	0.00	0.36
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	59.23	0.37	0.98	0.25	0.49	0.25	0.00	0.37
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	74.14	0.54	1.88	0.27	0.27	0.00	0.13	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	79.25	0.24	1.42	0.00	0.71	0.47	0.00	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	66.67	0.20	1.39	0.40	0.40	0.99	0.00	0.60
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	84.42	0.70	0.70	1.40	0.70	0.47	0.00	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	74.86	0.00	1.04	0.00	0.83	0.41	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	72.56	0.22	1.11	0.66	0.00	0.22	0.00	0.22
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	57.65	0.21	1.04	0.00	0.21	0.21	0.00	0.42
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	63.93	0.67	1.21	0.54	0.40	0.27	0.00	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	46.83	0.00	1.19	0.17	0.17	0.17	0.00	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	61.31	0.00	0.96	0.19	1.35	0.00	0.00	0.96
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	71.70	0.52	0.69	0.34	1.03	0.52	0.00	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	54.59	0.27	0.55	0.27	0.27	0.00	0.00	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	71.91	0.33	1.31	0.66	0.82	0.33	0.00	0.49
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	71.41	0.51	1.02	0.34	0.85	0.51	0.00	0.17
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	82.56	1.33	0.74	0.59	1.18	0.15	0.00	1.33
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	59.44	0.27	1.60	0.27	0.00	0.27	0.00	1.07
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	54.48	0.28	1.24	0.28	0.14	0.00	0.00	0.28
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	79.76	0.71	1.43	0.24	0.00	0.00	0.00	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	65.30	0.00	1.81	0.60	0.00	0.00	0.00	0.81
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	60.08	0.28	1.22	0.09	0.00	0.00	0.00	0.66
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	61.84	0.70	2.10	0.35	0.00	0.00	0.00	0.35
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	46.24	0.30	2.12	0.00	0.00	0.00	0.00	0.91
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	64.38	0.49	1.47	0.00	0.00	0.24	0.00	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	89.95	0.73	1.60	0.29	0.00	0.00	0.00	1.46
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	113.17	0.61	1.22	1.22	0.61	0.00	0.00	1.83
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	68.42	0.60	0.90	0.30	0.00	0.00	0.00	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	93.64	0.45	1.81	0.45	0.00	0.00	0.00	0.45
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	91.96	0.00	2.70	0.60	0.00	0.00	0.00	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	97.65	0.12	0.59	0.59	0.00	0.24	0.00	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	101.81	0.21	1.92	1.28	0.00	0.00	0.00	0.85
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	79.93	1.80	0.60	1.20	0.00	0.00	0.00	0.00
Schwann Cells, donor1	11498-119F4	114.35	1.13	1.32	0.38	0.00	0.38	0.00	1.13
Schwann Cells, donor2	11578-120F3	561.40	3.40	0.00	3.40	0.00	0.00	0.00	0.00
Schwann Cells, donor3	11659-122F3	264.65	0.88	2.19	1.31	0.44	0.00	0.00	1.31
Sebocyte, donor1	11220-116B5	411.92	9.86	2.74	0.00	1.64	0.00	0.00	1.64
Sebocyte, donor2	11301-117B5	202.20	3.68	1.84	2.30	0.00	0.00	0.00	0.00
Sebocyte, donor3	11378-118B1	218.69	2.47	2.89	0.41	0.21	0.21	0.21	1.86
Sertoli Cells, donor1	11255-116F4	1109.92	6.63	3.31	1.66	1.66	0.00	0.00	1.66
Sertoli Cells, donor2	11333-117F1	641.13	5.65	0.00	5.65	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor1	11281-116I3	107.86	1.06	1.32	0.18	0.09	0.00	0.00	0.53
Skeletal Muscle Cells, donor2	11358-117H8	46.26	0.00	3.61	0.72	0.00	0.00	0.00	0.00
Skeletal Muscle Cells, donor3	11430-118G8	239.94	1.67	5.02	0.00	0.00	0.00	0.00	0.84
Skeletal Muscle Cells, donor4	11451-119A2	205.01	1.26	1.26	1.73	0.31	0.79	0.16	0.94
Skeletal Muscle Cells, donor5	11455-119A6	153.70	3.12	1.64	1.04	0.00	0.15	0.15	1.93
Skeletal Muscle Cells, donor6	11459-119B1	353.36	2.77	2.62	2.00	0.31	0.62	0.00	1.54
Skeletal Muscle Satellite Cells, donor1	11240-116D7	199.22	2.14	1.39	0.63	0.13	0.13	0.00	1.51
Skeletal Muscle Satellite Cells, donor2	11321-117D7	157.24	1.43	1.57	0.57	0.00	0.14	0.00	1.57
Skeletal Muscle Satellite Cells, donor3	11397-118D2	251.30	0.40	2.58	0.69	0.40	0.20	0.00	1.29
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	103.80	0.84	1.52	0.25	0.25	0.67	0.00	0.84
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	190.35	1.45	2.17	1.45	0.00	0.00	0.00	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	197.87	1.93	1.51	1.79	0.14	0.28	0.14	1.24
Skin - palm, donor1	10286-104F7	110.13	2.69	2.69	0.00	0.00	0.00	0.00	0.00
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	359.09	3.46	2.31	1.73	0.14	0.29	0.00	1.73
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	700.11	2.45	4.09	2.45	0.82	0.00	0.00	3.27
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	238.88	2.60	1.43	1.56	0.26	0.13	0.00	0.65
Small Airway Epithelial Cells, donor1	11256-116F5	479.99	6.81	1.67	1.81	0.14	0.00	0.00	1.95
Small Airway Epithelial Cells, donor2	11334-117F2	277.38	4.78	1.41	3.24	0.00	0.00	0.00	0.84
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	668.59	15.65	4.23	0.21	0.00	0.42	0.00	2.54
Small Airway Epithelial Cells, donor3	11406-118E2	106.88	2.10	0.52	0.37	0.07	0.00	0.00	0.37
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	135.16	1.23	3.39	2.16	0.31	0.93	0.00	1.85
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	1251.50	3.33	1.33	3.56	0.67	2.00	0.00	1.56
Smooth Muscle Cells - Aortic, donor0	11210-116A4	577.25	8.23	2.35	1.76	0.00	1.18	0.00	3.53
Smooth Muscle Cells - Aortic, donor1	11283-116I5	514.69	2.65	0.88	1.10	0.44	1.10	0.00	1.99
Smooth Muscle Cells - Aortic, donor2	11360-117I1	584.37	4.73	1.97	1.58	0.79	0.79	0.00	0.79
Smooth Muscle Cells - Aortic, donor3	11432-118H1	593.33	3.09	3.86	1.55	0.77	2.32	0.00	3.86
Smooth Muscle Cells - Bladder, donor1	11519-119H7	116.09	2.00	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	876.72	9.71	3.06	1.60	1.06	1.33	0.00	2.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	1124.01	13.08	5.10	10.64	1.99	3.55	0.00	2.66
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	720.17	6.53	3.97	7.43	1.54	3.84	0.00	3.84
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	291.73	0.65	3.91	0.65	0.00	0.00	0.00	1.95
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	516.82	1.48	3.54	0.30	0.00	0.00	0.00	2.07
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	231.48	1.71	0.85	1.00	0.28	0.00	0.00	1.71
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	122.82	0.00	1.30	0.33	0.00	0.00	0.00	0.98
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	157.70	0.30	2.13	0.61	0.00	0.00	0.00	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	794.56	2.78	4.29	2.02	0.25	1.52	0.00	2.78
Smooth Muscle Cells - Carotid, donor2	11362-117I3	367.24	0.00	6.12	6.12	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	561.71	0.48	2.86	3.34	0.95	0.95	0.00	1.43
Smooth Muscle Cells - Colonic, donor1	11239-116D6	209.56	1.33	1.03	0.74	0.00	0.00	0.00	1.18
Smooth Muscle Cells - Colonic, donor2	11320-117D6	184.89	0.43	1.29	0.86	0.22	0.22	0.00	0.86
Smooth Muscle Cells - Colonic, donor3	11396-118D1	217.16	0.73	2.20	1.05	0.10	0.00	0.00	1.99
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	548.80	4.02	2.47	0.62	0.15	0.46	0.00	2.78
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	427.92	2.16	3.23	0.00	0.00	0.00	0.00	5.39
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	417.80	5.08	1.20	4.48	0.00	1.20	0.00	1.49
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	73.40	0.34	0.00	0.00	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	218.63	4.32	1.49	0.71	0.00	0.08	0.00	0.86
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	1167.94	13.99	4.43	1.61	0.60	0.50	0.00	3.93
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	881.77	7.05	2.73	6.37	0.68	1.14	0.00	3.87
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	410.59	6.04	1.21	4.83	1.21	0.00	0.00	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	511.31	1.32	5.30	0.79	1.06	0.79	0.00	3.71
Smooth Muscle Cells - Prostate, donor1	11257-116F6	297.88	1.73	0.93	0.40	0.13	0.13	0.00	0.93
Smooth Muscle Cells - Prostate, donor2	11335-117F3	321.94	1.75	2.38	1.13	0.00	0.00	0.00	2.50
Smooth Muscle Cells - Prostate, donor3	11465-119B7	671.19	3.30	4.06	2.79	1.52	1.27	0.00	2.03
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	1191.71	6.18	4.67	2.56	0.60	1.66	0.00	4.52
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	628.64	10.50	2.25	4.50	0.75	0.00	0.00	5.25
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	254.57	2.58	2.58	1.29	0.00	0.00	0.00	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	645.05	3.72	1.86	4.19	0.47	1.86	0.00	3.26
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	1016.83	5.05	5.05	8.08	1.51	2.02	0.00	3.03
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	697.93	2.82	3.13	5.95	1.88	1.25	0.00	2.51
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	189.98	0.88	2.06	0.29	0.00	0.29	0.00	0.59
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	566.74	5.17	3.67	1.33	0.17	1.17	0.08	3.25
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	199.48	2.80	0.47	0.93	0.00	0.00	0.00	0.93
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	662.17	3.31	3.02	1.73	0.72	1.44	0.00	1.44
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	526.99	4.08	3.82	3.31	1.02	1.27	0.00	1.02
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	376.07	3.76	1.13	2.63	0.19	0.56	0.00	1.69
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	404.56	1.96	3.07	0.14	0.00	0.28	0.00	1.40
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	333.23	2.18	1.76	0.42	0.00	0.00	0.00	0.84
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	67.62	0.48	0.00	0.95	0.00	0.00	0.00	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	631.96	3.43	3.67	0.73	0.00	0.49	0.00	2.69
Smooth Muscle Cells - Uterine, donor1	11258-116F7	370.97	3.31	1.33	0.88	0.00	0.00	0.00	1.10
Smooth Muscle Cells - Uterine, donor3	11466-119B8	475.73	1.17	3.80	2.05	0.59	0.29	0.00	2.63
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	349.07	2.53	2.14	0.97	0.00	0.00	0.00	0.97
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	515.15	4.50	2.91	2.12	0.79	0.00	0.00	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	977.85	7.44	1.49	3.72	0.00	0.37	0.00	2.23
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	587.52	5.75	2.87	1.08	0.00	0.72	0.36	2.52
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	550.48	1.99	4.54	2.56	0.00	0.00	0.00	1.14
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	449.01	2.36	2.36	1.97	1.18	0.39	0.00	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	583.58	3.05	1.78	4.32	0.25	0.00	0.00	2.54
Smooth muscle cells - airway, control, donor2	11967-126D5	396.12	5.19	1.60	2.00	0.00	0.00	0.00	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	525.01	6.69	2.09	5.43	0.00	0.00	0.00	1.67
Smooth muscle cells - airway, control, donor4	11969-126D7	468.90	3.67	4.13	1.83	0.00	0.46	0.00	0.46
Synoviocyte, donor1	11291-117A4	676.48	5.55	2.86	1.68	3.37	3.70	0.00	1.35
Synoviocyte, donor2	11368-117I9	575.62	5.36	3.35	3.35	0.67	0.17	0.00	2.01
Synoviocyte, donor3	11440-118H9	316.57	4.24	2.23	3.57	0.45	0.45	0.00	1.79
Trabecular Meshwork Cells, donor1	11532-120A2	101.12	0.00	0.36	0.00	0.00	0.00	0.00	1.07
Trabecular Meshwork Cells, donor2	11612-122A1	25.77	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	35.66	0.23	0.46	0.00	0.00	0.00	0.00	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	231.18	7.31	1.51	0.65	0.07	0.07	0.00	0.50
Tracheal Epithelial Cells, donor2	11369-118A1	169.31	1.16	0.77	1.55	0.00	0.00	0.00	1.55
Tracheal Epithelial Cells, donor3	11441-118I1	171.80	1.72	0.57	1.15	0.00	0.00	0.00	1.72
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	522.11	10.33	1.97	1.97	12.30	5.29	16.49	1.11
Urethra, donor2	10319-105A4	111.50	3.60	1.80	0.00	0.00	0.00	0.00	3.60
Urothelial Cells, donor1	11520-119H8	237.24	0.27	1.33	0.27	0.53	0.00	0.00	0.80
Urothelial Cells, donor2	11600-120H7	205.89	3.20	0.40	0.40	0.40	0.40	0.00	1.60
Urothelial Cells, donor3	11681-122H7	164.57	1.60	1.60	0.92	0.23	0.00	0.00	0.46
Urothelial cells, donor0	11216-116B1	996.34	17.83	3.57	2.23	0.22	0.45	0.00	1.78
Whole blood (ribopure), donor090309, donation1	12179-129A1	73.85	0.89	0.00	0.89	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation2	12180-129A2	82.92	0.00	0.00	1.43	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	21.22	0.68	0.68	0.68	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090325, donation1	12176-128I7	40.29	0.69	0.69	0.00	0.00	0.00	0.00	0.34
Whole blood (ribopure), donor090325, donation2	12177-128I8	41.25	0.58	1.16	0.00	0.00	0.00	0.00	0.58
Whole blood (ribopure), donor090612, donation1	12182-129A4	52.06	1.04	1.04	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation2	12183-129A5	55.99	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Whole blood (ribopure), donor090612, donation3	12184-129A6	33.78	0.00	0.00	0.00	0.00	0.00	0.00	0.91
Wilms' tumor cell line:G-401	10809-111A8	37.87	0.49	1.85	0.12	0.00	0.00	0.00	0.99
Wilms' tumor cell line:HFWT	10597-108E3	14.96	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	548.02	12.01	12.29	1.12	0.00	0.00	0.00	5.31
achilles tendon, donor2	10292-104G4	111.59	2.07	2.07	0.00	2.07	0.00	2.07	0.00
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	55.07	0.25	2.29	0.51	0.00	0.00	0.00	0.25
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	10.91	0.46	0.70	0.00	0.00	0.00	0.00	0.23
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	101.97	1.78	3.44	0.00	0.00	0.00	0.12	0.95
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	78.37	0.54	4.08	0.27	0.00	0.00	0.00	1.90
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	1.12	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	225.44	0.00	2.96	0.42	0.00	0.00	0.00	2.54
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	25.32	0.54	0.54	0.27	0.00	0.00	0.00	0.82
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	37.89	0.00	2.20	0.00	0.00	0.00	0.00	0.44
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	198.05	1.63	2.45	0.41	0.00	0.00	0.00	1.23
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	63.29	0.39	5.44	0.39	0.00	0.00	0.00	2.72
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	58.51	0.55	2.39	0.18	0.00	0.00	0.00	0.37
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	140.42	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	95.04	0.70	4.42	0.00	0.00	0.00	0.00	1.39
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	32.62	1.04	1.04	0.26	0.00	0.00	0.00	1.04
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	20.75	0.29	1.17	0.29	0.00	0.00	0.00	0.88
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	1.39	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	40.71	0.41	0.00	0.00	0.00	0.00	0.00	0.41
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	4.30	0.31	1.53	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	11.95	0.00	1.71	0.00	0.00	0.00	0.00	0.43
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	10.92	0.00	0.30	0.00	0.00	0.00	0.00	0.61
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	10.11	0.00	0.72	0.00	0.00	0.00	0.00	0.48
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	64.04	0.67	0.67	0.33	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	148.66	3.72	3.72	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	22.60	0.00	1.88	0.00	0.00	0.00	0.00	0.75
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	1.31	0.00	0.44	0.00	0.00	0.00	0.00	0.00
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	63.73	0.00	3.75	0.00	0.00	0.00	0.00	1.87
adenocarcinoma cell line:IM95m	10796-110I4	59.82	0.47	1.41	0.24	0.00	0.00	0.00	0.71
adipose tissue, adult, pool1	10010-101C1	498.09	6.52	2.79	3.57	0.00	0.31	0.16	2.02
adipose, donor1	10184-103D4	112.00	5.28	5.28	0.00	0.00	0.00	0.00	1.76
adipose, donor2	10185-103D5	32.44	1.22	4.06	0.00	0.00	0.00	0.00	2.43
adipose, donor3	10186-103D6	50.92	1.09	2.45	0.00	0.00	0.00	0.00	1.36
adipose, donor4	10187-103D7	33.80	0.87	0.87	0.87	0.00	0.00	0.00	0.00
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	35.35	0.16	5.05	0.16	0.00	0.00	0.00	2.68
adrenal gland, adult, pool1	10081-102A9	130.96	0.00	10.91	0.00	0.00	0.00	0.00	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	165.42	5.07	3.74	0.67	1.07	1.87	0.40	1.73
alveolar cell carcinoma cell line:SW 1573	10708-109H6	214.38	3.93	2.50	0.36	0.00	0.00	0.00	1.79
amniotic membrane cells, donor1	12235-129G3	2639.61	23.88	9.74	8.11	6.96	6.03	2.32	4.87
amniotic membrane cells, donor2	12236-129G4	1563.05	1.35	5.07	5.07	0.00	0.34	14.54	2.70
amniotic membrane cells, donor3	12237-129G5	1476.54	24.75	6.78	5.01	3.83	2.36	1.47	4.42
amygdala - adult, donor10196	10167-103B5	317.79	0.00	2.37	0.00	0.00	0.00	0.00	1.19
amygdala, adult, donor10252	10151-102I7	227.30	3.85	6.29	0.61	0.00	0.00	0.00	2.64
amygdala, newborn, donor10223	10360-105E9	132.34	2.26	1.94	0.32	0.00	0.32	0.00	0.97
anaplastic carcinoma cell line:8305C	10428-106D5	222.57	2.29	2.42	0.76	0.00	0.00	0.00	0.76
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	152.67	1.10	2.65	0.44	1.54	5.07	0.00	1.10
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	101.55	2.67	0.67	0.33	0.00	0.33	0.00	0.00
aorta, adult, pool1	10052-101G7	287.92	4.31	3.53	1.37	0.20	0.39	0.00	1.37
appendix, adult	10189-103D9	132.74	3.49	3.49	1.94	0.00	0.00	0.00	1.16
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	57.44	1.03	1.03	0.00	0.00	0.00	0.00	0.69
artery, adult	10190-103E1	350.54	8.15	2.72	5.43	0.00	0.00	0.00	1.36
astrocytoma cell line:TM-31	10425-106D2	374.34	3.91	1.74	0.87	0.43	0.43	0.00	1.74
b cell line:RPMI1788	10427-106D4	46.25	0.74	2.08	0.00	0.00	0.00	0.15	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	1122.00	8.32	4.16	2.77	1.39	2.77	0.00	2.50
bile duct carcinoma cell line:HuCCT1	10432-106D9	398.91	7.84	1.98	0.69	0.79	0.30	0.00	1.19
bile duct carcinoma cell line:TFK-1	10496-107C1	39.17	1.17	1.00	0.00	0.00	0.00	0.00	0.00
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bladder, adult, pool1	10011-101C2	266.28	3.59	2.82	0.87	0.11	0.22	0.00	0.76
blood, adult, pool1	10053-101G8	39.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
bone marrow stromal cell line:StromaNKtert	10686-109F2	943.69	5.99	4.28	0.00	0.00	0.86	0.00	2.57
bone marrow, adult	10192-103E3	207.17	2.70	3.37	2.02	0.00	0.67	0.00	0.00
brain, adult, donor1	10084-102B3	118.91	1.03	5.13	3.08	0.00	0.00	0.00	2.05
brain, adult, pool1	10012-101C3	224.83	0.78	3.45	1.22	0.00	0.00	0.00	1.45
brain, fetal, pool1	10085-102B4	45.41	0.00	2.67	0.00	0.00	0.00	0.00	0.00
breast carcinoma cell line:MCF7	10482-107A5	88.54	1.32	2.97	0.66	0.66	0.00	1.32	0.66
breast carcinoma cell line:MDA-MB-453	10419-106C5	45.81	1.00	1.00	0.00	0.12	0.00	0.12	0.50
breast, adult, donor1	10080-102A8	321.99	3.16	1.26	1.89	0.63	0.00	0.00	1.89
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	117.89	1.27	3.18	0.25	0.00	0.00	0.00	1.02
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	49.17	0.62	1.86	0.00	0.00	0.00	0.00	1.55
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	1097.22	22.79	5.76	4.60	29.24	17.96	3.22	7.37
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	101.43	0.97	1.21	0.73	0.24	0.24	2.42	0.48
carcinoid cell line:NCI-H1770	10703-109H1	22.57	2.35	0.47	0.00	0.00	0.00	0.00	0.47
carcinoid cell line:NCI-H727	10735-110B6	19.58	0.11	0.77	0.00	0.00	0.00	0.00	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	32.01	0.32	0.95	0.00	0.00	0.00	0.00	0.63
carcinosarcoma cell line:JHUCS-1	10642-109A3	28.75	0.00	0.80	0.00	0.00	0.00	0.00	1.06
caudate nucleus - adult, donor10196	10177-103C6	384.54	2.30	5.76	1.15	0.00	0.00	0.00	3.45
caudate nucleus, adult, donor10252	10164-103B2	268.56	3.01	3.35	1.00	0.00	0.00	0.00	2.84
caudate nucleus, adult, donor10258	10379-105H1	185.69	2.29	3.82	0.00	0.00	0.00	0.00	2.29
caudate nucleus, newborn, donor10223	10354-105E3	153.82	1.10	2.93	1.10	0.00	0.00	0.00	1.83
cerebellum - adult, donor10196	10173-103C2	332.11	0.00	8.74	2.91	0.00	0.00	0.00	0.00
cerebellum, adult, donor10252	10166-103B4	251.30	4.48	7.26	0.64	0.00	0.21	0.00	1.92
cerebellum, adult, pool1	10083-102B2	179.72	1.38	3.79	1.03	0.00	0.00	0.00	1.38
cerebellum, newborn, donor10223	10357-105E6	191.80	2.49	2.49	3.32	0.83	0.00	0.00	0.00
cerebral meninges, adult	10188-103D8	210.28	2.77	3.53	0.25	0.00	0.00	0.00	3.03
cerebrospinal fluid, donor2	10294-104G6	76.74	0.73	4.39	1.46	0.73	0.00	0.00	0.73
cervical cancer cell line:D98-AH2	10552-107I3	156.29	3.16	3.02	0.14	0.14	0.00	2.01	1.15
cervical cancer cell line:ME-180	10553-107I4	139.70	3.31	1.49	0.17	0.50	0.00	0.00	0.17
cervix, adult, pool1	10013-101C4	307.41	4.09	2.83	1.36	0.00	0.00	0.00	1.26
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	359.63	3.62	3.48	0.42	0.00	0.14	0.14	1.67
chondrosarcoma cell line:SW 1353	10700-109G7	163.28	1.31	3.92	0.00	0.00	0.00	0.00	1.31
choriocarcinoma cell line:BeWo	10423-106C9	28.71	0.50	0.62	0.00	0.62	1.86	1.62	0.25
choriocarcinoma cell line:SCH	10785-110H2	121.49	2.34	0.37	0.25	0.37	0.37	7.15	0.12
choriocarcinoma cell line:T3M-3	10618-108G6	16.60	0.71	1.19	0.00	0.00	0.00	0.00	0.00
chorionic membrane cells, donor1	12238-129G6	1155.06	10.26	6.84	5.98	5.98	11.11	3.13	3.13
chorionic membrane cells, donor2	12239-129G7	643.42	4.37	1.19	1.49	0.80	1.09	1.39	1.99
chorionic membrane cells, donor3	12240-129G8	833.57	11.54	0.55	5.49	7.69	12.09	7.69	2.75
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	58.57	0.00	2.02	2.02	0.00	0.00	0.00	0.00
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	68.00	0.58	1.15	0.19	0.19	0.77	0.19	0.58
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	39.91	0.21	1.90	1.06	0.00	0.00	0.00	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	49.05	1.28	1.28	0.26	0.00	0.00	0.00	1.03
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	57.08	0.24	0.73	0.24	0.00	0.24	0.00	0.97
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	62.92	0.81	1.83	0.81	0.00	0.00	0.00	0.81
chronic myelogenous leukemia cell line:K562	10454-106G4	127.79	0.88	1.77	0.59	0.00	0.00	0.29	0.88
chronic myelogenous leukemia cell line:KU812	10409-106B4	39.62	0.52	0.52	0.00	0.00	0.00	0.00	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	156.35	1.14	2.06	1.60	0.00	0.00	0.00	1.14
clear cell carcinoma cell line:TEN	10636-108I6	125.62	1.21	0.35	0.35	0.00	0.00	0.00	0.52
colon carcinoma cell line:CACO-2	10513-107D9	83.47	0.73	1.28	0.18	0.18	0.00	0.00	0.73
colon carcinoma cell line:COLO-320	10420-106C6	37.63	0.38	2.66	0.00	0.00	0.00	0.00	1.14
colon, adult, donor1	10082-102B1	157.08	2.38	4.76	0.00	0.00	0.00	0.00	0.00
colon, adult, pool1	10014-101C5	195.29	3.64	1.76	0.82	0.00	0.00	0.00	0.71
colon, fetal, donor1	10070-101I7	93.93	7.42	1.85	0.00	0.00	0.00	0.00	1.24
common myeloid progenitor CMP, donor1	12130-128D6	9.17	0.00	4.58	0.00	0.00	0.00	0.00	0.00
common myeloid progenitor CMP, donor2	12134-128E1	100.15	0.00	25.04	0.00	0.00	0.00	0.00	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	57.37	1.27	0.42	0.85	0.00	0.00	0.00	0.42
cord blood derived cell line:COBL-a 24h infection	10453-106G3	59.17	0.45	1.21	0.00	0.00	0.30	0.00	1.06
cord blood derived cell line:COBL-a untreated	10449-106F8	74.31	1.27	1.13	0.00	0.14	0.00	0.00	0.56
corpus callosum, adult, pool1	10042-101F6	185.63	1.11	3.76	0.22	0.00	0.00	0.00	1.22
cruciate ligament, donor2	10295-104G7	117.52	2.43	2.43	0.00	0.00	0.81	0.81	2.43
diaphragm, fetal, donor1	10069-101I6	174.16	8.03	0.80	1.61	0.00	0.00	0.00	0.00
diencephalon, adult	10193-103E4	157.91	2.88	5.28	0.72	0.00	0.00	0.00	1.44
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	21.58	0.23	1.84	0.23	0.00	0.00	0.00	0.23
ductal cell carcinoma cell line:KLM-1	10438-106E6	68.21	0.26	1.28	0.00	0.00	0.00	0.00	1.03
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	60.90	1.44	0.72	0.48	0.00	0.00	0.00	0.24
ductus deferens, adult	10196-103E7	348.34	1.50	2.49	1.50	0.00	0.00	0.50	0.50
duodenum, fetal, donor1, tech_rep1	10071-101I8	167.07	2.88	1.44	0.00	0.00	0.00	0.00	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	178.76	1.47	0.74	3.68	0.00	0.00	0.00	0.74
dura mater, adult, donor1	10041-101F5	393.28	1.73	3.30	0.50	0.25	0.00	0.00	2.40
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	69.29	1.33	0.89	0.00	0.00	0.00	0.00	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	82.68	2.15	1.86	0.14	0.00	0.00	0.00	2.15
embryonic pancreas cell line:1B2C6	10604-108F1	119.62	3.08	3.08	0.00	0.00	0.00	0.00	1.23
embryonic pancreas cell line:1C3D3	10605-108F2	235.21	2.42	3.33	3.03	0.00	0.30	0.00	1.21
embryonic pancreas cell line:1C3IKEI	10606-108F3	125.97	1.23	1.23	0.62	0.00	0.00	0.00	0.00
embryonic pancreas cell line:2C6	10603-108E9	207.53	0.00	1.31	1.31	0.00	0.00	0.00	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	100.22	1.01	0.67	0.00	0.00	0.00	0.00	1.68
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	520.15	6.16	5.80	1.99	0.00	0.00	0.00	3.26
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	151.65	0.48	2.25	1.61	0.00	0.00	0.00	1.29
epidermoid carcinoma cell line:A431	10426-106D3	121.94	1.89	0.56	0.33	0.11	0.11	0.00	0.89
epidermoid carcinoma cell line:Ca Ski	10431-106D8	278.70	3.85	2.09	0.77	0.22	0.33	0.00	1.87
epididymis, adult	10197-103E8	308.32	3.77	1.67	2.09	0.00	0.00	0.00	2.72
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	368.66	7.81	4.08	1.06	0.00	0.18	0.00	2.48
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	91.63	0.39	0.00	0.39	0.00	0.00	0.00	0.39
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	289.88	3.54	4.19	2.36	6.29	3.93	4.85	2.36
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	227.84	3.25	4.72	1.28	2.26	3.54	4.04	1.87
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	272.79	3.70	4.82	1.90	4.48	3.36	3.81	1.90
esophagus, adult, pool1	10015-101C6	348.26	5.31	3.50	1.91	0.11	0.11	0.11	1.27
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	72.01	0.75	1.38	0.13	0.00	0.00	0.00	1.50
eye - muscle inferior rectus, donor1	10272-104E2	335.63	4.83	0.00	0.00	0.00	0.00	4.83	2.41
eye - muscle lateral, donor2	10298-104H1	105.21	4.21	6.31	0.00	0.00	0.00	0.00	2.10
eye - muscle medial, donor2	10299-104H2	141.38	2.98	4.46	0.00	0.00	0.00	0.00	0.00
eye - muscle superior, donor2	10297-104G9	160.51	2.29	6.88	0.00	0.00	0.00	0.00	2.29
eye - vitreous humor, donor1	10268-104D7	36.43	0.00	1.46	0.00	0.00	1.46	0.00	1.46
eye, fetal, donor1	10054-101G9	242.79	5.08	3.56	0.76	0.00	0.51	0.00	0.76
fibrosarcoma cell line:HT-1080	10758-110E2	334.79	5.39	3.46	1.15	3.85	5.39	0.13	1.67
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	260.92	7.36	3.80	0.47	1.42	0.95	0.00	2.61
frontal lobe, adult, pool1	10040-101F4	185.02	1.22	3.10	0.19	0.00	0.00	0.00	1.50
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	99.08	0.60	0.90	0.30	0.00	0.60	0.00	1.50
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	122.34	1.37	0.73	0.09	0.73	1.10	0.18	0.73
gall bladder, adult	10198-103E9	320.62	4.59	3.14	2.17	0.24	0.00	0.00	0.48
gamma delta positive T cells, donor1	11937-126A2	39.73	0.54	1.61	0.54	0.54	0.00	0.00	0.00
gamma delta positive T cells, donor2	11938-126A3	41.46	1.12	2.24	0.37	0.00	0.00	0.00	0.37
gastric adenocarcinoma cell line:MKN1	10614-108G2	168.97	0.63	1.27	1.06	0.00	0.00	0.00	0.42
gastric adenocarcinoma cell line:MKN45	10612-108F9	55.51	0.58	1.35	0.19	0.00	0.00	0.00	0.19
gastric cancer cell line:AZ521	10549-107H9	47.22	0.33	3.93	0.33	0.00	0.00	0.00	1.15
gastric cancer cell line:GSS	10560-108A2	25.63	0.92	0.92	0.92	0.00	0.00	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	52.09	0.00	1.60	0.46	0.00	0.00	0.00	0.46
giant cell carcinoma cell line:LU65	10487-107B1	78.25	1.84	0.11	0.11	0.23	0.34	0.00	0.11
giant cell carcinoma cell line:Lu99B	10433-106E1	346.96	5.46	4.62	0.56	0.42	0.56	0.00	4.06
glassy cell carcinoma cell line:HOKUG	10688-109F4	85.05	0.50	1.00	1.00	0.00	0.50	0.00	1.50
glioblastoma cell line:A172, tech_rep1	10444-106F3	201.50	3.59	2.85	0.32	0.32	0.11	0.00	0.84
glioblastoma cell line:A172, tech_rep2	10444-106F3	215.01	2.81	1.69	0.56	0.42	0.14	0.00	2.11
glioblastoma cell line:T98G	10485-107A8	97.35	1.66	2.54	0.00	0.00	0.00	0.00	0.88
glioma cell line:GI-1	10413-106B8	53.89	0.29	1.17	0.00	0.00	0.00	0.00	0.00
globus pallidus - adult, donor10196	10175-103C4	306.14	0.00	8.02	0.00	0.00	0.00	0.73	1.46
globus pallidus, adult, donor10252	10161-103A8	227.50	4.88	5.13	0.73	0.24	0.24	0.00	0.49
globus pallidus, adult, donor10258	10367-105F7	182.10	1.37	5.48	0.00	0.00	0.00	0.00	0.00
globus pallidus, newborn, donor10223	10364-105F4	240.88	4.80	1.07	0.00	1.07	1.07	0.00	1.60
granulocyte macrophage progenitor, donor1	12131-128D7	19.58	0.00	2.45	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	98.36	0.00	0.00	0.00	0.00	0.00	0.00	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	125.44	0.00	0.00	0.00	0.00	0.00	0.00	20.91
granulosa cell tumor cell line:KGN	10624-108H3	264.64	2.24	1.92	1.28	0.32	0.32	0.00	1.28
hIPS +CCl2, biol_rep1	14383-156B9	44.99	0.46	0.00	0.00	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep2	14384-156C1	41.61	0.46	0.46	0.46	0.00	0.00	0.00	0.00
hIPS +CCl2, biol_rep3	14385-156C2	44.44	0.00	0.64	0.00	0.00	0.00	0.00	0.64
hIPS, biol_rep1	14380-156B6	56.05	0.00	0.00	0.00	0.00	0.00	0.00	1.44
hIPS, biol_rep2	14381-156B7	43.21	0.69	0.69	0.00	0.00	0.00	0.00	1.37
hIPS, biol_rep3	14382-156B8	200.83	1.10	3.31	0.00	0.00	0.00	0.00	3.31
hairy cell leukemia cell line:Mo	10712-109I1	3.74	0.29	0.00	0.00	0.00	0.57	0.00	0.00
heart - mitral valve, adult	10205-103F7	348.90	6.28	2.09	1.49	0.30	0.00	0.00	1.79
heart - pulmonic valve, adult	10206-103F8	226.70	2.88	3.40	0.26	0.00	0.00	0.00	1.31
heart - tricuspid valve, adult	10207-103F9	600.33	21.65	1.67	4.16	4.16	3.33	1.67	5.00
heart, adult, diseased post-infarction, donor1	10050-101G5	364.24	4.29	3.06	2.45	0.82	1.43	0.20	1.84
heart, adult, diseased, donor1	10051-101G6	677.50	11.92	6.39	2.55	0.43	1.28	0.43	2.98
heart, adult, pool1	10016-101C7	490.77	14.72	3.45	1.38	0.69	0.69	0.46	1.61
heart, fetal, pool1	10046-101G1	307.32	3.80	3.90	0.21	0.10	0.00	0.31	1.85
hepatic mesenchymal tumor cell line:LI90	10778-110G4	456.92	6.17	1.85	1.23	0.31	0.31	0.00	1.23
hepatoblastoma cell line:HuH-6	10633-108I3	39.24	0.00	0.00	0.00	0.00	0.00	0.00	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	83.87	0.88	1.66	0.22	0.00	0.00	0.00	1.22
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	91.27	1.09	2.79	0.36	0.00	0.00	0.00	1.21
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	83.57	0.71	1.72	0.10	0.00	0.00	0.00	1.72
hepatoma cell line:Li-7	10484-107A7	65.62	1.33	0.44	0.00	0.00	0.00	0.00	0.11
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	28.94	0.20	1.51	0.00	0.00	0.00	0.00	0.70
hippocampus - adult, donor10196	10169-103B7	290.52	2.84	4.73	3.79	0.00	0.00	0.00	3.79
hippocampus, adult, donor10252	10153-102I9	226.35	2.65	3.06	0.82	0.00	0.00	0.00	2.65
hippocampus, adult, donor10258	10374-105G5	158.85	0.50	0.50	0.50	0.00	0.00	0.00	1.00
hippocampus, newborn, donor10223	10363-105F3	113.50	3.17	1.41	0.00	0.00	0.35	0.00	1.06
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	67.75	2.44	1.83	1.22	0.00	0.00	0.00	0.61
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	34.36	0.39	0.98	0.20	0.00	0.00	0.00	0.39
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	35.55	0.76	1.02	0.00	0.00	0.00	0.00	0.76
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	31.58	1.69	3.95	0.56	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	36.67	0.52	1.81	1.29	0.00	0.00	0.00	0.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	45.17	1.90	2.28	0.76	0.00	0.00	0.00	1.14
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	63.94	0.88	3.80	0.00	0.00	0.00	0.29	0.58
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	53.86	1.08	2.80	0.22	0.00	0.00	0.00	1.08
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	80.08	2.50	3.75	1.25	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	128.10	0.47	4.03	1.89	0.00	0.00	0.00	0.95
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	83.09	1.29	3.21	0.48	0.00	0.00	0.16	1.77
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	113.79	0.00	3.37	0.00	0.00	0.00	0.00	2.69
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	38.96	0.94	0.47	0.63	0.00	0.00	0.00	0.16
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	48.64	0.00	1.97	1.97	0.00	0.00	0.00	0.00
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	41.02	2.62	0.87	0.87	0.00	0.00	0.00	0.87
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	50.40	1.53	1.91	0.38	0.00	0.00	0.00	1.53
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	50.15	1.31	0.87	1.31	0.00	0.00	0.00	0.44
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	73.96	0.00	2.00	1.50	0.00	0.00	0.00	1.00
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	46.16	1.32	3.39	0.57	0.00	0.00	0.00	0.94
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	58.66	0.00	3.64	0.45	0.00	0.00	0.00	0.91
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	48.86	0.94	3.76	0.63	0.00	0.00	0.00	0.63
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	79.69	0.82	2.29	0.49	0.00	0.16	0.00	0.98
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	93.77	0.29	3.19	0.29	0.00	0.00	0.00	1.16
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	60.68	1.20	2.39	0.30	0.00	0.00	0.00	1.20
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	38.98	2.22	0.92	0.55	0.00	0.00	0.00	0.37
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	37.09	2.00	1.14	0.00	0.00	0.00	0.00	0.57
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	63.29	2.04	2.04	0.82	0.00	0.00	0.00	0.82
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	60.21	0.70	0.70	1.06	0.00	0.00	0.00	0.35
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	45.29	0.63	1.27	0.95	0.00	0.00	0.00	1.27
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	53.26	0.91	2.42	0.61	0.00	0.00	0.00	0.61
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	51.71	0.52	4.65	1.55	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	63.76	0.66	1.33	0.66	0.00	0.00	0.00	1.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	53.87	1.28	4.62	0.26	0.00	0.00	0.00	1.03
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	94.85	1.28	2.81	1.79	0.00	0.00	0.00	1.02
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	66.64	1.51	4.54	0.76	0.00	0.00	0.00	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	88.38	0.67	0.67	0.34	0.34	0.00	0.00	0.34
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	43.23	1.69	1.45	0.24	0.00	0.00	0.00	0.72
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	40.11	0.89	0.45	0.89	0.00	0.00	0.00	0.89
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	43.42	0.98	1.46	0.49	0.00	0.00	0.00	0.49
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	33.62	0.92	1.83	0.31	0.00	0.00	0.00	0.92
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	191.94	13.01	0.00	3.25	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	65.53	0.66	0.99	1.65	0.00	0.00	0.00	0.99
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	53.64	1.64	2.74	0.55	0.55	0.00	0.00	0.55
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	52.47	1.45	3.62	0.36	0.00	0.00	0.36	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	48.04	1.07	2.49	0.71	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	50.12	1.19	2.39	0.00	0.00	0.00	0.00	0.00
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	84.91	0.41	3.39	0.14	0.00	0.00	0.00	1.76
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	55.50	2.16	3.23	0.54	0.00	0.00	0.00	1.35
immature langerhans cells, donor1	11904-125F5	385.01	2.18	2.91	0.48	1.45	4.12	0.00	2.66
immature langerhans cells, donor2	11905-125F6	223.38	1.58	1.58	0.00	0.79	6.34	0.00	0.79
insula, adult, pool1	10039-101F3	193.43	0.76	3.79	0.09	0.00	0.00	0.00	2.46
keratoacanthoma cell line:HKA-1	10791-110H8	75.43	0.00	2.28	0.33	0.00	0.00	0.00	0.65
kidney, adult, pool1	10017-101C8	576.93	8.41	3.10	1.60	0.30	0.00	0.40	1.70
kidney, fetal, pool1	10045-101F9	187.66	1.77	2.55	0.21	0.00	0.00	0.07	0.99
large cell lung carcinoma cell line:IA-LM	10509-107D5	340.85	9.94	2.84	0.28	1.28	0.28	0.00	1.85
large cell lung carcinoma cell line:NCI-H460	10839-111E2	49.77	0.28	0.69	0.28	0.28	0.00	0.00	0.41
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	50.46	0.37	0.18	0.00	0.00	0.00	0.00	0.18
left atrium, adult, donor1	10079-102A7	285.50	3.27	3.81	1.09	0.00	0.00	0.00	0.54
left ventricle, adult, donor1	10078-102A6	492.00	9.10	3.03	2.53	0.00	1.01	0.00	1.52
leiomyoblastoma cell line:G-402	10721-110A1	71.69	0.55	0.27	0.00	0.00	0.00	0.00	0.27
leiomyoma cell line:10964C	10569-108B2	917.88	6.47	6.47	12.93	0.00	0.36	0.00	2.51
leiomyoma cell line:15242A	10570-108B3	552.72	4.89	7.07	7.07	0.54	0.54	0.00	1.63
leiomyoma cell line:15425	10571-108B4	1030.27	5.58	5.34	13.35	0.24	0.49	0.00	4.13
leiomyosarcoma cell line:Hs 5.T	10722-110A2	857.16	0.00	6.35	6.35	0.00	0.00	0.00	6.35
lens epithelial cell line:SRA 01/04	10647-109A8	163.11	1.05	2.09	2.09	0.00	0.00	0.00	4.18
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	53.24	0.94	1.06	0.12	0.00	0.35	0.00	0.59
liposarcoma cell line:KMLS-1	10782-110G8	267.12	1.41	1.87	1.25	0.78	0.16	0.31	0.62
liposarcoma cell line:SW 872	10726-110A6	289.37	2.80	2.44	0.49	0.24	0.12	0.00	0.85
liver, adult, pool1	10018-101C9	265.94	1.62	2.11	0.16	0.16	0.16	0.00	1.13
liver, fetal, pool1	10086-102B5	107.24	0.00	0.00	0.94	0.00	0.00	0.00	1.88
locus coeruleus - adult, donor10196	10182-103D2	252.86	3.94	8.60	1.02	0.00	0.15	0.00	3.06
locus coeruleus, adult, donor10252	10165-103B3	270.74	3.32	6.46	1.29	0.00	0.18	0.00	3.32
locus coeruleus, adult, donor10258	10375-105G6	266.34	1.41	6.77	2.26	0.00	0.00	0.00	2.82
locus coeruleus, newborn, donor10223	10362-105F2	407.58	3.79	2.52	1.68	0.00	0.00	0.00	2.52
lung adenocarcinoma cell line:A549	10499-107C4	34.05	0.55	1.80	0.00	0.00	0.00	0.14	0.55
lung adenocarcinoma cell line:PC-14	10408-106B3	79.28	0.00	0.69	0.00	0.00	0.69	0.00	2.76
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	50.75	0.66	1.19	0.00	0.53	0.00	0.00	0.66
lung, adult, pool1	10019-101D1	546.10	8.74	2.60	1.06	0.00	0.47	0.12	1.65
lung, fetal, donor1	10068-101I5	442.38	2.57	3.71	0.29	0.00	0.00	0.00	2.28
lung, right lower lobe, adult, donor1	10075-102A3	325.79	9.62	5.04	2.29	0.00	0.00	0.00	1.83
lymph node, adult, donor1	10077-102A5	172.78	0.47	1.89	1.42	0.00	0.95	0.00	0.47
lymphangiectasia cell line:DS-1	10727-110A7	123.40	0.44	2.19	0.44	0.00	0.00	0.00	1.10
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	57.35	0.75	2.11	0.15	0.00	0.00	0.00	0.75
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	192.84	3.40	0.00	0.00	1.70	3.40	0.00	0.00
mature adipocyte, donor1	12231-129F8	177.60	2.22	3.55	0.44	0.44	0.44	0.00	1.33
mature adipocyte, donor2	12232-129F9	347.19	3.11	4.36	0.42	0.21	1.04	0.00	2.70
mature adipocyte, donor3	12233-129G1	223.79	1.66	3.08	0.24	0.47	0.47	0.00	1.19
mature adipocyte, donor4	12234-129G2	153.46	0.79	2.90	0.00	0.00	0.53	0.00	1.05
maxillary sinus tumor cell line:HSQ-89	10414-106B9	16.20	0.71	1.91	0.00	0.00	0.00	0.00	0.00
medial frontal gyrus - adult, donor10196	10170-103B8	294.42	2.26	7.90	4.51	0.00	0.00	0.00	2.26
medial frontal gyrus, adult, donor10252	10150-102I6	219.77	2.39	4.41	0.55	0.00	0.00	0.00	1.66
medial frontal gyrus, adult, donor10258	10368-105F8	159.48	2.54	2.22	0.32	0.00	0.00	0.00	3.18
medial frontal gyrus, newborn, donor10223	10352-105E1	224.33	2.99	2.13	0.00	0.00	0.43	0.00	1.28
medial temporal gyrus - adult, donor10196	10183-103D3	247.05	0.84	5.40	4.89	0.84	0.34	0.00	2.53
medial temporal gyrus, adult, donor10252	10156-103A3	193.12	3.18	4.03	0.21	0.00	0.21	0.00	1.27
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	225.37	0.00	1.93	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	315.78	43.06	14.35	0.00	0.00	0.00	0.00	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	109.12	0.72	2.87	0.36	0.00	0.00	0.00	0.00
medulla oblongata - adult, donor10196	10174-103C3	577.59	6.49	6.49	1.30	0.00	0.65	0.00	0.65
medulla oblongata, adult, donor10252	10155-103A2	279.73	3.87	5.26	0.62	0.00	0.00	0.00	2.32
medulla oblongata, adult, pool1	10038-101F2	265.70	1.71	6.12	0.49	0.16	0.00	0.00	1.80
medulla oblongata, newborn, donor10223	10361-105F1	205.18	2.08	7.29	1.04	0.35	0.35	0.00	2.08
medulloblastoma cell line:D283 Med	10838-111E1	15.72	0.00	1.33	0.00	0.00	0.00	0.00	0.00
medulloblastoma cell line:ONS-76	10759-110E3	163.36	0.73	1.71	0.37	0.00	0.00	0.00	1.47
melanoma cell line:COLO 679	10514-107E1	212.17	2.87	2.59	0.43	0.00	0.29	0.00	2.16
melanoma cell line:G-361	10465-106H6	336.89	5.97	1.36	0.81	0.00	0.00	0.00	1.63
meningioma cell line:HKBMM	10691-109F7	233.37	3.44	1.09	1.99	1.63	2.17	0.00	1.09
merkel cell carcinoma cell line:MKL-1	10843-111E6	29.96	1.76	3.52	0.00	0.00	0.00	0.00	0.88
merkel cell carcinoma cell line:MS-1	10844-111E7	37.85	0.52	1.56	0.00	0.00	0.00	0.00	0.52
mesenchymal precursor cell - adipose, donor1	11747-123G1	391.10	2.15	1.69	1.69	0.31	0.61	0.15	1.84
mesenchymal precursor cell - adipose, donor2	11748-123G2	185.23	1.09	0.36	0.55	0.00	0.36	0.00	0.91
mesenchymal precursor cell - adipose, donor3	11749-123G3	469.18	0.41	2.07	1.24	0.83	0.83	0.00	2.07
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	482.39	5.62	2.11	1.69	0.28	0.14	0.00	1.12
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	501.83	2.50	1.35	2.50	0.00	0.19	0.00	0.58
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	647.57	2.78	2.08	1.39	0.00	0.69	0.00	2.08
mesenchymal precursor cell - cardiac, donor1	11752-123G6	297.79	1.72	2.06	1.37	0.00	0.17	0.00	2.40
mesenchymal precursor cell - cardiac, donor2	11753-123G7	449.14	2.65	2.30	1.84	0.00	0.46	0.00	1.38
mesenchymal precursor cell - cardiac, donor3	11754-123G8	425.10	3.18	1.59	2.52	0.13	1.06	0.27	1.72
mesenchymal precursor cell - cardiac, donor4	11755-123G9	673.04	4.73	1.76	2.03	1.62	3.11	0.14	2.43
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	453.11	5.12	1.71	2.13	0.57	1.00	0.00	1.56
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	206.83	1.32	2.31	0.33	0.00	0.00	0.00	1.98
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	364.19	2.91	1.94	1.66	0.14	0.28	0.00	2.08
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	756.81	4.89	4.19	1.75	0.00	0.35	0.00	2.09
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	609.23	5.92	1.22	3.06	0.82	1.02	0.00	1.43
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	243.71	4.31	0.72	0.36	0.00	0.36	0.00	0.72
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	284.18	1.66	1.97	0.83	0.00	0.00	0.00	0.83
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	262.87	7.07	1.82	1.60	0.00	0.00	0.00	0.00
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	519.83	1.68	5.03	2.52	0.42	0.84	0.00	0.84
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	407.07	3.44	3.29	1.49	0.30	0.90	0.30	0.75
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	253.84	2.80	2.10	1.31	0.09	0.18	0.00	1.66
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	549.29	2.21	0.37	1.10	0.00	0.00	0.00	1.10
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	350.83	6.01	2.58	1.43	0.29	0.29	0.00	1.72
mesenchymal stem cell line:Hu5/E18	10568-108B1	538.48	8.42	3.37	6.74	2.11	1.26	0.00	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	343.87	2.28	2.28	1.83	0.00	0.46	0.00	2.28
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	369.86	1.79	2.30	1.02	0.26	0.77	0.00	2.30
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	355.73	1.31	4.19	0.79	0.26	0.52	0.00	1.57
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	296.38	1.85	2.46	0.92	0.31	0.00	0.00	2.77
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	363.86	1.65	0.94	3.29	0.47	1.18	0.24	1.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	344.89	2.37	4.74	1.02	0.00	0.00	0.00	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	322.63	2.36	2.75	3.93	0.39	0.39	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	298.88	1.85	2.32	1.39	0.46	0.00	0.00	0.93
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	338.13	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	473.58	0.87	3.17	2.31	0.87	0.58	0.29	2.88
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	355.85	1.78	4.46	0.89	0.00	0.22	0.00	1.12
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	350.43	2.88	2.40	1.20	0.24	0.24	0.00	1.68
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	354.93	0.73	4.40	4.40	0.00	0.00	0.00	1.47
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	307.46	2.35	2.69	1.01	0.00	0.34	0.00	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	309.90	0.41	2.46	2.05	0.41	0.00	0.00	2.05
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	332.05	1.72	1.29	0.43	0.00	0.43	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	412.90	2.73	2.73	2.73	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	428.69	5.16	10.33	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	419.95	1.30	3.90	1.95	0.00	0.32	0.00	1.30
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	400.12	0.00	1.45	2.91	0.00	0.00	0.00	2.91
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	450.45	1.07	2.13	3.20	0.00	0.00	0.00	1.07
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	342.65	3.27	4.91	2.45	0.00	0.00	0.00	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	356.46	2.33	1.94	1.55	0.39	0.00	0.00	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	384.07	4.20	2.10	4.20	0.00	0.00	0.00	2.10
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	358.64	3.97	3.97	1.99	0.00	0.99	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	390.91	0.00	0.00	0.00	4.77	0.00	0.00	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	399.07	3.56	4.15	1.78	1.19	0.00	0.00	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	416.71	0.00	4.87	0.00	0.00	0.00	0.00	1.22
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	432.84	0.00	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	428.17	1.27	5.07	3.17	0.00	0.63	0.00	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	348.70	2.07	3.79	1.03	0.00	0.34	0.00	0.34
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	322.38	0.00	0.00	8.60	0.00	0.00	0.00	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	343.29	7.98	3.99	3.99	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	292.73	0.00	0.00	10.33	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	269.34	2.44	2.85	2.04	0.41	0.00	0.00	0.41
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	296.33	3.97	0.79	1.59	0.00	0.00	0.00	1.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	183.34	2.36	1.18	0.59	0.00	0.00	0.00	0.59
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	173.62	1.87	2.49	0.62	0.00	0.00	0.00	2.49
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	229.91	1.34	5.35	4.01	0.00	0.00	0.00	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	137.19	2.37	1.18	3.55	0.00	0.00	0.00	1.18
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	138.67	2.57	0.00	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	150.07	1.38	2.07	0.69	0.00	0.00	0.00	0.69
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	103.41	1.98	1.98	0.49	0.00	0.00	0.00	0.99
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	91.96	2.24	2.24	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	102.41	1.27	1.91	0.64	0.00	0.00	0.00	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	118.88	1.61	4.43	0.00	0.00	0.00	0.00	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	104.67	2.18	8.72	4.36	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	115.30	5.07	1.27	1.27	0.00	0.00	0.00	2.53
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	69.79	1.21	3.03	0.61	0.00	0.00	0.00	0.61
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	112.97	9.04	4.52	0.00	0.00	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	73.31	1.65	4.12	0.82	0.00	0.00	0.00	2.47
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	221.84	1.79	2.38	0.40	0.00	0.00	0.00	1.39
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	162.25	1.95	3.24	1.30	0.00	0.00	0.00	0.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	164.00	0.00	1.02	2.04	0.00	0.00	0.00	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	273.89	1.55	2.32	0.00	0.00	1.55	0.00	3.87
mesothelioma cell line:ACC-MESO-1	10493-107B7	186.39	3.78	3.31	0.24	0.71	0.24	0.00	0.94
mesothelioma cell line:ACC-MESO-4	10494-107B8	138.31	1.39	2.55	0.00	0.00	0.00	0.00	1.62
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	264.96	8.55	0.00	4.27	0.00	0.00	0.00	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	572.11	3.08	2.06	2.16	0.72	1.54	0.00	2.47
mesothelioma cell line:Mero-25	10850-111F4	28.37	0.23	0.68	0.68	0.00	0.00	0.00	0.45
mesothelioma cell line:Mero-41	10851-111F5	323.69	2.93	1.96	0.49	0.00	0.24	0.00	0.98
mesothelioma cell line:Mero-48a	10852-111F6	303.36	2.66	1.33	0.66	0.00	0.00	0.00	0.89
mesothelioma cell line:Mero-82	10853-111F7	156.63	1.58	2.37	0.26	0.26	0.00	0.00	0.79
mesothelioma cell line:Mero-83	10854-111F8	172.77	2.55	0.85	0.85	0.00	0.00	0.00	0.68
mesothelioma cell line:Mero-84	10855-111F9	122.85	1.01	1.77	0.51	0.00	0.00	0.25	0.51
mesothelioma cell line:Mero-95	10856-111G1	113.25	1.45	1.04	0.00	0.00	0.00	0.00	0.00
mesothelioma cell line:NCI-H2052	10847-111F1	295.68	4.31	4.64	0.83	0.00	0.33	0.00	1.66
mesothelioma cell line:NCI-H226	10846-111E9	154.02	2.90	1.27	0.54	0.00	0.18	0.00	1.09
mesothelioma cell line:NCI-H2452	10848-111F2	339.77	4.95	3.25	1.88	1.37	0.51	0.00	1.37
mesothelioma cell line:NCI-H28	10845-111E8	33.59	0.00	1.53	0.00	0.00	0.00	0.00	0.25
mesothelioma cell line:No36	10857-111G2	92.97	0.33	1.30	0.33	2.94	2.94	0.33	0.33
mesothelioma cell line:ONE58	10858-111G3	216.22	2.17	1.35	0.81	0.54	0.27	0.00	0.81
migratory langerhans cells, donor1	11901-125F2	102.68	0.19	1.54	0.00	0.19	0.77	0.00	1.15
migratory langerhans cells, donor2	11902-125F3	138.11	0.24	1.83	0.12	0.00	0.12	0.00	1.59
migratory langerhans cells, donor3	11903-125F4	149.51	0.36	3.23	0.36	0.36	0.18	0.00	1.08
mixed mullerian tumor cell line:HTMMT	10689-109F5	66.60	2.29	0.98	0.98	0.00	0.00	0.00	0.33
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	126.74	0.85	1.48	0.85	0.64	0.00	0.00	0.64
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	186.59	1.61	1.84	0.92	0.92	0.00	0.00	2.07
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	108.47	1.71	1.71	0.19	0.57	2.47	0.38	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	128.06	1.85	3.14	0.55	0.00	0.18	0.00	1.29
myeloma cell line:PCM6	10474-106I6	220.00	2.57	3.76	0.40	0.00	0.00	0.00	1.19
myxofibrosarcoma cell line:MFH-ino	10600-108E6	237.92	4.06	4.06	1.52	0.00	0.51	0.00	1.52
myxofibrosarcoma cell line:NMFH-1	10684-109E9	256.35	1.37	1.96	0.78	0.39	0.59	0.00	1.18
nasal epithelial cells, donor1, tech_rep1	12226-129F3	119.00	0.78	1.23	0.22	0.22	0.00	0.00	0.67
nasal epithelial cells, donor1, tech_rep2	12226-129F3	138.48	1.62	0.88	0.37	0.15	0.07	0.00	0.59
nasal epithelial cells, donor2	12227-129F4	252.81	0.55	2.21	1.66	0.00	0.00	0.00	0.55
neuroblastoma cell line:CHP-134	10508-107D4	20.02	0.23	0.92	0.00	0.00	0.00	0.00	0.23
neuroblastoma cell line:NB-1	10539-107G8	66.42	0.37	1.68	0.00	0.00	0.00	0.00	1.31
neuroblastoma cell line:NBsusSR	10607-108F4	36.27	0.21	0.21	0.00	0.00	0.00	0.00	0.42
neuroblastoma cell line:NH-12	10555-107I6	31.68	0.00	2.42	0.19	0.00	0.00	0.00	0.19
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	25.15	0.95	1.90	0.47	0.00	0.00	0.00	0.00
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	52.27	1.58	0.63	0.16	0.00	0.00	0.00	0.79
neuroectodermal tumor cell line:TASK1	10774-110F9	36.83	1.01	1.41	0.00	0.00	0.00	0.00	0.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	25.43	0.64	0.64	0.00	0.00	0.00	0.00	0.00
neurofibroma cell line:Hs 53.T	10729-110A9	424.00	3.99	2.40	0.00	0.80	0.80	0.00	1.33
neutrophil PMN, donor1	12133-128D9	74.37	0.00	14.87	0.00	0.00	0.00	0.00	0.00
neutrophil PMN, donor2	12137-128E4	239.05	0.00	0.00	0.00	0.00	0.00	0.00	13.28
neutrophil PMN, donor3	12141-128E8	265.18	0.00	0.00	0.00	0.00	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	96.57	1.18	7.44	0.00	0.00	0.00	0.00	2.37
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	128.88	1.60	5.60	0.00	0.00	0.00	0.00	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	557.53	2.56	1.28	2.56	0.96	0.00	0.00	1.92
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	225.45	1.84	2.89	2.10	0.00	0.00	0.00	1.31
nucleus accumbens, adult, pool1	10037-101F1	212.79	1.59	3.37	0.37	0.00	0.09	0.00	1.78
occipital cortex - adult, donor10196	10172-103C1	321.42	0.00	0.00	2.06	0.00	0.00	0.00	0.00
occipital cortex, adult, donor10252	10163-103B1	229.99	6.44	3.49	1.07	0.27	0.27	0.00	1.34
occipital cortex, newborn, donor10223	10355-105E4	110.27	2.91	0.73	0.73	0.73	0.00	0.00	1.09
occipital lobe, adult, donor1	10076-102A4	155.34	3.15	4.46	2.36	0.00	0.00	0.00	1.84
occipital lobe, fetal, donor1	10073-102A1	54.92	0.43	3.00	0.00	0.00	0.00	0.00	1.72
occipital pole, adult, pool1	10036-101E9	146.72	0.71	2.92	0.24	0.00	0.00	0.00	1.89
olfactory region, adult	10195-103E6	144.05	1.91	3.82	1.53	0.00	0.00	0.00	1.72
optic nerve, donor1	10277-104E7	112.06	8.00	2.00	2.00	0.00	0.00	0.00	0.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	54.33	0.80	0.68	0.11	0.00	0.00	0.00	0.34
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	97.27	0.69	1.92	0.14	0.00	0.00	0.00	1.24
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	163.23	1.86	0.68	1.02	0.00	0.00	0.00	1.02
oral squamous cell carcinoma cell line:SAS	10544-107H4	85.25	1.04	0.46	0.23	0.35	0.00	0.00	0.81
osteoclastoma cell line:Hs 706.T	10704-109H2	290.44	1.76	2.35	0.59	2.94	1.76	0.00	1.76
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	210.23	0.93	3.74	0.00	1.87	2.80	0.00	1.87
osteosarcoma cell line:HS-Os-1	10558-107I9	52.38	0.42	0.64	0.00	0.00	0.00	0.00	0.64
ovary, adult, pool1	10020-101D2	212.79	2.71	1.40	0.44	0.09	0.00	0.00	1.05
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	111.09	0.92	0.73	0.37	0.18	0.37	0.00	0.18
pancreas, adult, donor1	10049-101G4	267.14	5.64	1.88	1.88	0.00	0.00	0.00	0.00
pancreatic carcinoma cell line:NOR-P1	10698-109G5	12.30	0.28	0.28	0.00	0.28	0.00	0.00	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	1537.78	12.95	4.60	11.24	4.77	1.70	3.92	3.07
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	768.47	4.31	1.99	1.99	0.33	0.00	0.00	1.16
paracentral gyrus, adult, pool1	10035-101E8	198.05	1.28	4.30	0.00	0.00	0.00	0.00	2.75
parietal cortex, adult, donor10258	10373-105G4	179.10	0.73	4.40	0.73	0.00	0.00	0.00	1.47
parietal lobe - adult, donor10196	10171-103B9	223.84	0.94	3.76	0.00	1.88	0.00	0.00	0.94
parietal lobe, adult, donor10252	10157-103A4	190.40	3.14	1.43	0.57	0.00	0.00	0.00	1.71
parietal lobe, adult, pool1	10034-101E7	214.57	1.23	2.82	0.18	0.00	0.00	0.00	2.56
parietal lobe, fetal, donor1	10072-101I9	60.13	0.00	6.79	0.00	0.00	0.00	0.00	0.97
parietal lobe, newborn, donor10223	10356-105E5	126.74	1.12	1.50	1.12	0.37	0.00	0.00	0.00
parotid gland, adult	10199-103F1	282.43	4.32	2.47	1.23	0.00	0.00	0.00	0.00
penis, adult	10200-103F2	279.30	9.67	4.83	3.76	0.00	0.00	0.00	1.07
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	15.62	0.00	0.74	0.00	0.00	0.00	0.00	0.00
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	892.67	7.58	9.03	3.21	0.87	0.58	0.00	5.25
pineal gland - adult, donor10196	10179-103C8	387.02	0.00	6.45	1.94	0.00	0.65	0.65	3.23
pineal gland, adult, donor10252	10160-103A7	309.73	1.18	2.37	0.59	0.00	0.00	0.00	1.78
pineal gland, adult, donor10258	10377-105G8	206.31	0.63	1.25	3.14	0.00	0.00	0.00	1.25
pituitary gland - adult, donor10196	10180-103C9	420.91	1.01	4.05	0.00	0.00	0.00	0.00	2.02
pituitary gland, adult, donor10252	10162-103A9	542.55	1.56	3.65	0.52	0.00	0.00	0.00	3.65
pituitary gland, adult, donor10258	10378-105G9	283.46	4.26	6.81	2.55	0.00	0.00	0.00	4.26
placenta, adult, pool1	10021-101D3	1350.45	8.92	5.38	3.01	61.92	26.45	59.88	3.55
plasma cell leukemia cell line:ARH-77	10840-111E3	56.94	0.13	1.59	0.26	0.00	0.66	0.00	0.40
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	299.45	2.96	1.25	0.78	0.00	0.16	0.31	1.56
pons, adult, pool1	10033-101E6	261.73	1.81	9.47	0.43	0.00	0.17	0.09	3.96
postcentral gyrus, adult, pool1	10032-101E5	175.40	1.74	4.01	0.61	0.00	0.00	0.00	2.01
promyelocytes/myelocytes PMC, donor1	12132-128D8	43.92	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	247.86	0.00	0.00	0.00	0.00	0.00	0.00	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	328.60	0.00	0.00	0.00	0.00	0.00	0.00	0.00
prostate cancer cell line:DU145	10490-107B4	83.17	1.89	2.04	0.44	0.00	0.29	0.00	1.46
prostate cancer cell line:PC-3	10439-106E7	343.76	5.99	4.54	1.27	0.36	0.36	0.00	1.27
prostate, adult, pool1	10022-101D4	272.71	2.63	3.26	0.54	0.00	0.00	0.00	0.63
putamen, adult, donor10196	10176-103C5	292.72	3.07	4.96	0.71	0.00	0.00	0.00	3.30
putamen, adult, donor10252	10152-102I8	311.76	9.80	3.92	5.88	0.00	0.00	0.00	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	149.71	0.00	1.09	0.00	0.00	0.00	0.00	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	200.30	2.66	2.42	0.24	0.00	0.00	0.00	2.42
putamen, newborn, donor10223	10365-105F5	304.36	1.50	0.75	0.75	0.75	0.75	0.00	1.50
rectal cancer cell line:TT1TKB	10469-106I1	17.75	0.87	0.58	0.00	0.00	0.00	0.00	0.00
rectum, fetal, donor1	10067-101I4	112.67	2.78	4.17	1.39	0.00	0.00	0.00	0.00
renal cell carcinoma cell line:OS-RC-2	10411-106B6	111.94	1.27	2.54	0.21	0.00	0.00	0.00	1.91
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	130.06	2.90	4.97	0.00	0.00	0.00	0.00	2.90
retina, adult, pool1	10030-101E3	367.48	2.88	3.78	0.89	0.00	0.00	0.00	1.79
retinoblastoma cell line:Y79	10475-106I7	26.50	0.52	2.08	0.00	0.00	0.00	0.00	0.52
rhabdomyosarcoma cell line:KYM-1	10787-110H4	334.91	5.29	3.93	0.49	0.00	0.00	0.00	1.48
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	34.59	0.84	5.06	0.00	0.00	0.00	0.00	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	145.51	1.52	1.52	0.00	0.00	0.00	0.00	2.27
salivary acinar cells, donor1	11771-123I7	334.07	3.40	1.13	1.46	0.16	0.16	0.00	1.29
salivary acinar cells, donor2	11772-123I8	240.26	2.07	1.93	0.55	0.00	0.00	0.00	0.55
salivary acinar cells, donor3	11773-123I9	117.85	1.32	1.32	0.00	0.00	0.00	0.00	0.66
salivary gland, adult, pool1	10093-102C3	637.73	6.86	1.14	1.14	0.00	0.00	0.00	0.57
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	142.57	1.85	1.60	0.17	0.00	0.08	0.00	0.93
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	157.75	2.23	2.12	0.59	0.00	0.00	0.00	0.59
seminal vesicle, adult	10201-103F3	257.66	3.70	3.70	2.12	0.00	0.00	0.53	0.53
serous adenocarcinoma cell line:JHOS-2	10639-108I9	191.18	2.92	2.19	1.21	0.24	0.00	0.00	0.97
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	339.20	1.26	3.27	0.50	0.75	0.75	0.00	2.01
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	365.29	3.01	2.01	1.00	1.00	1.00	0.00	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	43.92	0.67	0.67	0.00	0.00	0.00	0.00	0.40
signet ring carcinoma cell line:Kato III	10436-106E4	43.33	0.44	0.55	0.00	0.00	0.00	0.00	0.22
signet ring carcinoma cell line:NUGC-4	10483-107A6	430.69	3.48	1.94	0.39	0.00	0.00	0.00	1.55
skeletal muscle - soleus muscle, donor1	10282-104F3	226.28	3.55	4.97	0.71	0.00	0.71	0.00	1.42
skeletal muscle, adult, pool1	10023-101D5	382.72	6.60	5.28	0.60	0.24	0.24	0.84	2.64
skeletal muscle, fetal, donor1	10066-101I3	76.38	1.01	2.01	0.00	0.00	0.00	0.00	0.00
skin, adult, donor1	10074-102A2	284.98	6.79	0.00	0.00	0.00	0.00	0.00	6.79
skin, fetal, donor1	10065-101I2	159.70	0.63	1.89	1.89	0.00	0.00	0.00	0.63
small cell cervical cancer cell line:HCSC-1	10800-110I8	80.38	1.33	2.67	1.00	0.00	0.00	0.00	0.33
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	125.14	0.63	4.10	0.32	0.00	0.00	0.00	0.32
small cell lung carcinoma cell line:DMS 144	10841-111E4	13.49	0.00	3.28	0.39	0.00	0.00	0.00	0.00
small cell lung carcinoma cell line:LK-2	10541-107H1	30.99	0.99	0.66	0.16	0.00	0.00	0.00	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	9.33	0.48	2.41	0.00	0.00	0.00	0.00	0.32
small cell lung carcinoma cell line:WA-hT	10562-108A4	160.17	2.62	3.49	0.65	0.00	0.00	0.00	1.31
small intestine, adult, pool1	10024-101D6	129.72	2.03	1.55	0.12	0.00	0.00	0.00	0.96
small intestine, fetal, donor1	10064-101I1	93.86	0.98	1.72	0.25	0.00	0.00	0.00	1.47
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	79.50	1.54	1.03	1.03	0.00	0.00	0.00	0.00
smooth muscle, adult, pool1	10048-101G3	209.87	3.36	2.33	1.55	0.00	0.26	0.00	1.55
somatostatinoma cell line:QGP-1	10781-110G7	17.15	0.27	1.34	0.00	0.00	0.00	0.00	0.80
spinal cord - adult, donor10196	10181-103D1	255.56	1.61	6.19	1.15	0.46	0.00	0.00	1.84
spinal cord, adult, donor10252	10159-103A6	195.16	1.97	1.58	0.00	0.00	0.00	0.00	1.58
spinal cord, adult, donor10258	10369-105F9	296.78	1.38	5.53	0.69	0.00	0.00	0.00	2.08
spinal cord, fetal, donor1	10056-101H2	155.51	2.44	3.05	1.22	0.61	0.00	0.00	0.61
spinal cord, newborn, donor10223	10359-105E8	315.94	2.76	4.59	0.92	0.46	0.00	0.00	1.84
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	529.16	5.38	3.14	1.19	1.34	1.79	0.30	1.64
spleen, adult, pool1	10025-101D7	139.76	2.20	1.54	0.44	0.00	0.11	0.00	0.99
spleen, fetal, pool1	10044-101F8	120.22	0.95	2.54	0.24	0.08	0.08	0.00	1.35
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	65.63	0.72	3.21	0.10	0.00	0.00	0.00	2.17
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	75.95	2.28	1.71	0.00	0.38	0.38	0.00	0.57
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	165.99	0.35	3.49	0.70	0.35	1.40	0.00	1.40
squamous cell carcinoma cell line:T3M-5	10616-108G4	295.15	5.08	2.74	0.39	0.39	0.00	0.00	0.00
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	148.24	3.83	0.90	0.23	0.00	0.00	0.00	0.45
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	50.83	2.97	0.00	0.42	0.00	0.00	0.00	0.00
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	128.61	2.12	2.12	0.00	0.00	0.00	0.00	0.00
stomach, fetal, donor1	10062-101H8	214.66	1.07	4.27	3.20	0.00	0.00	0.00	1.07
submaxillary gland, adult	10202-103F4	370.86	3.42	2.85	3.42	0.00	0.00	0.00	1.71
substantia nigra - adult, donor10196	10178-103C7	379.92	54.27	0.00	0.00	0.00	0.00	0.00	0.00
substantia nigra, adult, donor10252	10158-103A5	205.63	3.95	3.95	1.45	0.00	0.21	0.21	0.62
substantia nigra, adult, donor10258	10371-105G2	253.45	2.07	3.62	0.52	0.00	0.00	0.00	3.10
substantia nigra, newborn, donor10223	10358-105E7	164.63	4.95	2.12	0.00	0.00	0.00	0.00	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	77.49	0.69	2.06	0.00	0.00	0.00	0.00	1.15
temporal lobe, adult, pool1	10031-101E4	160.39	1.61	2.88	0.34	0.00	0.00	0.00	1.70
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	47.72	0.00	1.42	1.42	0.00	0.00	0.00	1.42
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	52.74	0.00	1.76	0.00	0.00	0.00	0.00	0.00
tenocyte, donor1	11763-123H8	555.77	3.49	2.79	3.84	0.70	0.00	0.00	0.35
tenocyte, donor2	11765-123I1	914.47	8.01	3.05	4.96	0.38	1.53	0.00	1.53
tenocyte, donor3	11768-123I4	861.43	8.15	4.08	10.38	0.37	1.11	0.00	2.97
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	60.34	0.51	3.74	0.34	0.00	0.00	0.00	2.04
teratocarcinoma cell line:NCR-G1	10798-110I6	35.15	0.15	1.23	0.00	0.00	0.00	0.15	0.31
teratocarcinoma cell line:PA-1	10807-111A6	34.56	0.93	1.39	0.00	0.00	0.00	0.00	0.46
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	43.04	1.02	0.51	0.00	0.00	0.00	0.00	0.13
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	15.51	0.38	0.76	0.00	0.00	0.00	0.00	0.38
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	39.92	0.65	0.76	0.22	0.00	0.00	0.00	0.11
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	29.96	0.65	0.98	0.65	0.00	0.00	0.00	0.98
testis, adult, pool1	10026-101D8	254.69	3.11	4.40	1.18	0.21	0.00	0.00	1.61
testis, adult, pool2	10096-102C6	139.84	1.35	1.80	0.90	0.00	0.00	0.00	1.35
thalamus - adult, donor10196	10168-103B6	271.58	5.52	6.62	1.10	0.00	0.00	0.00	3.31
thalamus, adult, donor10252	10154-103A1	168.47	4.53	3.28	0.63	0.00	0.31	0.00	1.41
thalamus, adult, donor10258, tech_rep1	10370-105G1	380.29	0.00	1.54	0.00	0.00	0.00	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	133.73	1.65	5.93	0.49	0.00	0.00	0.00	1.98
thalamus, newborn, donor10223	10366-105F6	118.52	1.15	1.73	0.00	0.00	0.00	0.00	0.58
throat, adult	10209-103G2	293.86	3.99	6.49	1.75	0.00	0.00	0.00	1.50
throat, fetal, donor1	10061-101H7	160.58	3.35	4.27	0.00	0.00	0.00	0.00	0.91
thymic carcinoma cell line:Ty-82	10803-111A2	32.59	0.99	1.99	0.00	0.00	0.00	0.00	0.20
thymus, adult, pool1	10027-101D9	94.74	0.20	1.59	0.30	0.00	0.00	0.10	1.09
thymus, fetal, pool1	10043-101F7	135.49	1.45	2.18	0.10	0.00	0.10	0.21	1.45
thyroid carcinoma cell line:KHM-5M	10776-110G2	126.58	1.46	1.99	0.80	0.27	0.00	0.00	0.66
thyroid carcinoma cell line:TCO-1	10783-110G9	207.72	2.10	3.77	0.00	0.28	0.00	0.00	1.26
thyroid, adult, pool1	10028-101E1	550.08	7.00	3.17	1.49	0.09	0.09	0.19	1.68
thyroid, fetal, donor1	10060-101H6	193.79	5.01	5.01	2.11	0.00	0.26	0.00	2.37
tongue epidermis (fungiform papillae), donor1	10288-104F9	224.81	6.16	6.16	0.00	0.00	0.00	0.00	9.24
tongue, adult	10203-103F5	283.05	4.42	2.33	1.86	0.00	0.00	0.00	2.09
tongue, fetal, donor1	10059-101H5	400.00	10.64	6.70	1.97	0.00	0.00	0.00	3.94
tonsil, adult, pool1	10047-101G2	273.58	2.70	2.80	0.30	0.10	0.00	0.00	1.10
trachea, adult, pool1	10029-101E2	471.16	5.32	2.13	1.23	0.33	0.00	0.08	1.88
trachea, fetal, donor1	10058-101H4	245.05	1.92	1.15	0.77	0.00	0.00	0.00	2.31
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	390.41	5.31	2.48	1.06	0.35	0.00	0.00	1.42
transitional-cell carcinoma cell line:5637	10418-106C4	117.83	0.81	0.81	0.00	0.00	0.00	0.00	0.10
transitional-cell carcinoma cell line:JMSU1	10492-107B6	72.86	1.72	1.72	0.31	0.00	0.00	0.00	1.10
tridermal teratoma cell line:HGRT	10694-109G1	182.64	1.90	5.71	0.00	0.00	0.00	0.00	1.90
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	203.33	1.35	3.05	0.59	0.00	0.00	0.00	1.02
umbilical cord, fetal, donor1	10057-101H3	194.04	0.00	2.09	4.17	0.00	2.09	0.00	0.00
uterus, adult, pool1	10100-102D1	297.06	1.54	2.73	0.17	0.00	0.00	0.00	0.85
uterus, fetal, donor1	10055-101H1	156.65	1.54	3.07	1.54	0.00	0.00	0.00	3.07
vagina, adult	10204-103F6	310.18	0.65	1.94	3.23	0.65	0.00	0.00	1.29
vein, adult	10191-103E2	164.40	3.29	2.63	1.53	0.22	0.00	0.00	0.88
xeroderma pigentosum b cell line:XPL 17	10563-108A5	80.38	0.80	2.40	0.27	0.00	0.27	0.00	1.34